<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Chronic disease management programmes for adults with asthma - Peytremann‐Bridevaux, I - 2015 | Cochrane Library</title> <meta content="Chronic disease management programmes for adults with asthma - Peytremann‐Bridevaux, I - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007988.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Chronic disease management programmes for adults with asthma - Peytremann‐Bridevaux, I - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007988.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007988.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Chronic disease management programmes for adults with asthma" name="citation_title"/> <meta content="Isabelle Peytremann‐Bridevaux" name="citation_author"/> <meta content="Lausanne University Hospital" name="citation_author_institution"/> <meta content="isabelle.peytremann-bridevaux@chuv.ch" name="citation_author_email"/> <meta content="Chantal Arditi" name="citation_author"/> <meta content="Lausanne University Hospital" name="citation_author_institution"/> <meta content="Grégoire Gex" name="citation_author"/> <meta content="Hôpital du Valais" name="citation_author_institution"/> <meta content="Pierre‐Olivier Bridevaux" name="citation_author"/> <meta content="Bernard Burnand" name="citation_author"/> <meta content="Lausanne University Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD007988.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/05/27" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007988.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007988.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007988.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Disease Management; Asthma [*therapy]; Chronic Disease; Hospitalization; Quality of Life; Randomized Controlled Trials as Topic; Self Care [methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007988.pub2&amp;doi=10.1002/14651858.CD007988.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="dLyXbLct";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007988\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007988\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","hr","fr","ta","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007988.pub2",title:"Chronic disease management programmes for adults with asthma",firstPublishedDate:"May 27, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Effective Practice and Organisation of Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007988.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007988.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007988.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007988.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007988.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007988.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;ta&quot;,&quot;title&quot;:&quot;எளியமொழிச் சுருக்கம்&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007988.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007988.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007988.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007988.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8328 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007988.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-sec-0092"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-sec-0030"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-sec-0055"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-sec-0086"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/appendices#CD007988-sec-0097"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/table_n/CD007988StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/table_n/CD007988StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Chronic disease management programmes for adults with asthma</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information#CD007988-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Isabelle Peytremann‐Bridevaux</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information#CD007988-cr-0003">Chantal Arditi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information#CD007988-cr-0004">Grégoire Gex</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information#CD007988-cr-0005">Pierre‐Olivier Bridevaux</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information#CD007988-cr-0006">Bernard Burnand</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information/en#CD007988-sec-0104">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 27 May 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007988.pub2">https://doi.org/10.1002/14651858.CD007988.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007988-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007988-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007988-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007988-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007988-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007988-abs-0001" lang="en"> <section id="CD007988-sec-0001"> <h3 class="title" id="CD007988-sec-0001">Background</h3> <p>The burden of asthma on patients and healthcare systems is substantial. Interventions have been developed to overcome difficulties in asthma management. These include chronic disease management programmes, which are more than simple patient education, encompassing a set of coherent interventions that centre on the patients' needs, encouraging the co‐ordination and integration of health services provided by a variety of healthcare professionals, and emphasising patient self‐management as well as patient education. </p> </section> <section id="CD007988-sec-0002"> <h3 class="title" id="CD007988-sec-0002">Objectives</h3> <p>To evaluate the effectiveness of chronic disease management programmes for adults with asthma. </p> </section> <section id="CD007988-sec-0003"> <h3 class="title" id="CD007988-sec-0003">Search methods</h3> <p>Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Effective Practice and Organisation of Care (EPOC) Group Specialised Register, MEDLINE (MEDLINE In‐Process and Other Non‐Indexed Citations), EMBASE, CINAHL, and PsycINFO were searched up to June 2014. We also handsearched selected journals from 2000 to 2012 and scanned reference lists of relevant reviews. </p> </section> <section id="CD007988-sec-0004"> <h3 class="title" id="CD007988-sec-0004">Selection criteria</h3> <p>We included individual or cluster‐randomised controlled trials, non‐randomised controlled trials, and controlled before‐after studies comparing chronic disease management programmes with usual care in adults over 16 years of age with a diagnosis of asthma. The chronic disease management programmes had to satisfy at least the following five criteria: an organisational component targeting patients; an organisational component targeting healthcare professionals or the healthcare system, or both; patient education or self‐management support, or both; active involvement of two or more healthcare professionals in patient care; a minimum duration of three months. </p> </section> <section id="CD007988-sec-0005"> <h3 class="title" id="CD007988-sec-0005">Data collection and analysis</h3> <p>After an initial screen of the titles, two review authors working independently assessed the studies for eligibility and study quality; they also extracted the data. We contacted authors to obtain missing information and additional data, where necessary. We pooled results using the random‐effects model and reported the pooled mean or standardised mean differences (SMDs). </p> </section> <section id="CD007988-sec-0006"> <h3 class="title" id="CD007988-sec-0006">Main results</h3> <p>A total of 20 studies including 81,746 patients (median 129.5) were included in this review, with a follow‐up ranging from 3 to more than 12 months. Patients' mean age was 42.5 years, 60% were female, and their asthma was mostly rated as moderate to severe. Overall the studies were of moderate to low methodological quality, because of limitations in their design and the wide confidence intervals for certain results. </p> <p>Compared with usual care, chronic disease management programmes resulted in improvements in asthma‐specific quality of life (SMD 0.22, 95% confidence interval (CI) 0.08 to 0.37), asthma severity scores (SMD 0.18, 95% CI 0.05 to 0.30), and lung function tests (SMD 0.19, 95% CI 0.09 to 0.30). The data for improvement in self‐efficacy scores were inconclusive (SMD 0.51, 95% CI ‐0.08 to 1.11). Results on hospitalisations and emergency department or unscheduled visits could not be combined in a meta‐analysis because the data were too heterogeneous; results from the individual studies were inconclusive overall. Only a few studies reported results on asthma exacerbations, days off work or school, use of an action plan, and patient satisfaction. Meta‐analyses could not be performed for these outcomes. </p> </section> <section id="CD007988-sec-0007"> <h3 class="title" id="CD007988-sec-0007">Authors' conclusions</h3> <p>There is moderate to low quality evidence that chronic disease management programmes for adults with asthma can improve asthma‐specific quality of life, asthma severity, and lung function tests. Overall, these results provide encouraging evidence of the potential effectiveness of these programmes in adults with asthma when compared with usual care. However, the optimal composition of asthma chronic disease management programmes and their added value, compared with education or self‐management alone that is usually offered to patients with asthma, need further investigation. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007988-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007988-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007988-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007988-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007988-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007988-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007988-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007988-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/ta#CD007988-abs-0009">தமிழ்</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007988-abs-0004" lang="en"> <h3>Chronic disease management for asthma</h3> <p>Asthma is a chronic (long‐term) airway (breathing) disease affecting about 300 million people worldwide. People with asthma have many symptoms, such as wheezing, coughing and shortness of breath. The aim of a chronic disease management programme for asthma is to improve the quality and effectiveness of asthma care by creating a programme that is centred on patient's needs, encourages the co‐ordination of the health services provided by healthcare professionals such as doctors and nurses, who should work together, and focuses on helping the patients to manage their illness themselves as well as providing them with information to help them understand their illness. </p> <p>This review found 20 studies that compared the effects of chronic disease management programmes in adults with asthma with the effects of usual care. The average age of the patients was 42.5 years, 60% were women, and they had moderate to severe asthma. Overall the evidence that was found was of moderate to low quality. </p> <p>Chronic disease management programmes for adults with asthma probably improve patients' quality of life, reduce the severity of the asthma, and improve breathing as demonstrated by improved performance in lung function tests after 12 months. It is unclear whether chronic disease management programmes improve the patients' abilities to manage their own asthma or decrease the number of hospitalisations or emergency visits. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007988-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007988-sec-0092">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007988-sec-0134">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007988-sec-0092"></div> <h3 class="title" id="CD007988-sec-0093">Implications for practice</h3> <section id="CD007988-sec-0093"> <p>Our systematic review provides moderate to low evidence that CDM programmes have a clinically small but positive effect on asthma‐specific quality of life and asthma severity, which are among the main objectives of asthma management and are the most crucial outcomes for the everyday life of patients with asthma. Our results also showed that lung function tests (FEV1 and PEF) were slightly improved with the CDM programmes. </p> <p>Despite the moderate to low level of evidence, we can consider, overall, that the results of this systematic review represent encouraging evidence for the effectiveness of CDM programmes in adults with asthma. The development of CDM programmes must be with evidence of their benefits since the programmes are resource consuming and usually require organisational restructuring. Our data seem to be encouraging for further investment in the promotion, development, and evaluation of CDM programmes in asthma, a condition with a substantial burden for patients and healthcare systems. However, the optimal composition of asthma CDM programmes still needs further investigation, especially in terms of the specific components and the level of complexity. It seems very important to assess the benefits of CDM programmes with those from education or self‐management, or both, alone since the latter are usually offered to patients with asthma and represent usual care for a majority of healthcare professionals taking care of patients with asthma. This may be difficult since education, self‐management, and CDM programmes are not always readily distinguishable. </p> </section> <h3 class="title" id="CD007988-sec-0094">Implications for research</h3> <section id="CD007988-sec-0094"> <p>We suggest that researchers planning future studies on the effectiveness of chronic disease management for patients with asthma consider the following issues. </p> <p> <ol id="CD007988-list-0025"> <li> <p>Investigate the most responsive patients to determine whether a particular subpopulation of patients with asthma benefit more from CDM programmes than others. Future trials could categorise patients into subgroups according to disease severity or other criteria. </p> </li> <li> <p>Describe the CDM programme in detail to identify which of the CDM components are more beneficial than others to patients with asthma, and assess if complex or intensive programmes are needed, and what components could be added to the current patient education and self‐management support provided. Hence, future trials should report and assess the components of the CDM programmes in detail, including their frequency and intensity. Future trials should also try to compare education and self‐management support with CDM programmes directly, or to compare different types of CDM programmes, in terms of comprehensiveness and intensity, for example rather than comparing with usual care. </p> </li> <li> <p>Assess the impact of CDM on hospitalisations and emergency department or unscheduled visits more fully. </p> </li> <li> <p>Consider not only outcome of care indicators but also structure and process of care indicators. Since outcome indicators do not seem to be greatly improved, emphasis should be put on the assessment of structure and process of care indicators to better interpret the outcome results. </p> </li> <li> <p>Improve the quality and reporting of studies to increase the level of evidence and confidence in the results. It is crucial to improve both the quality of pragmatic studies assessing the effectiveness of these programmes and the quality of their reporting. Future trials describing methods and data collection more completely would increase the quality of the evidence for the results of systematic reviews. </p> </li> </ol> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007988-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007988-sec-0022"></div> <div class="table" id="CD007988-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Chronic disease management compared with usual care for adults with asthma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Chronic disease management compared with usual care for adults with asthma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with asthma<br/> <b>Settings:</b> 7 studies in primary care practices, 3 in outpatient hospital departments, 3 in pharmacies, 2 in health maintenance organisations (HMOs), 5 in mixed settings<br/> <b>Intervention:</b> chronic disease management<br/> <b>Comparison:</b> usual care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Usual care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Chronic disease management </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma‐specific quality of life score</b> <br/> Measured on different scales in different studies. Higher scores indicate higher quality of life.<br/> Follow‐up: 3 to 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean asthma‐specific quality of life score ranged across control groups from<br/> <b>3.8 to 5.3</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean asthma‐specific quality of life score in the intervention groups was<br/> <b>0.22 standard deviations higher</b> <br/> (0.08 to 0.37 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1627<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A SMD of 0.22 represents a small improvement in quality of life. On the AQLQ scale, it represents a mean difference of 0.31 (0.11 to 0.53). MCID of AQLQ = 0.5<sup>3,4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of hospitalisations per patient</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of hospitalisations per patient ranged across control groups from <b>0.06 to 1.23</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of hospitalisations per patient ranged across intervention groups from <b>0.02 to 0.4</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed;see comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data too heterogeneous to perform meta‐analysis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of emergency room or unscheduled visits</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of emergency room or unscheduled visits per patient ranged across control groups from <b>0.02 to 1.4</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of emergency room or unscheduled visits per patient ranged across intervention groups from <b>0.02 to 1.9</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed; see comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data too heterogeneous to perform meta‐analysis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma exacerbations</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed;see comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for meta‐analysis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐efficacy score</b><sup>5</sup> <br/> Measured on different scales in different studies. Higher scores indicate higher self‐efficacy<br/> Follow‐up: 3 to 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><sup>5</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐efficacy score in the intervention groups was<br/> <b>0.51 standard deviations higher</b> <br/> (0.08 lower to 1.11 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>642<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A SMD of 0.51 represents a moderate improvement in self‐efficacy<sup>3,8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma severity score</b><sup>5</sup> <br/> Measured on different scales in different studies. Higher scores indicate lower severity<br/> Follow‐up: 6‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean asthma severity score in the intervention groups was<br/> <b>0.18 standard deviations higher</b> <br/> (0.05 to 0.3 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1330<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>6,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A SMD of 0.18 represents a small improvement in asthma severity&lt;BR/&gt;<sup>3,8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Days off work</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed;see comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for meta‐analysis</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Values correspond to the AQLQ scores only<br/> <sup>2</sup> Downgraded because majority of studies were at high or unclear risk of bias<br/> <sup>3</sup> As a rule of thumb: SMD &lt; 0.40 = small effect, SMD 0.40 to 0.70 = moderate effect, SMD &gt; 0.70 = large effect<br/> <sup>4</sup> The score was estimated using a SD of 1.43 (control group of Gallbreath's study)<br/> <sup>5</sup> No assumed risk presented for usual groups because too much variation in the instruments or scales used<br/> <sup>6</sup> Downgraded because of clinical, statistical and measurement heterogeneity<br/> <sup>7</sup> Wide 95% CIs<br/> <sup>8</sup> Back‐transformation was not performed because all studies used another instrument or scale<br/> <sup>9</sup> Downgraded because three studies were at high risk of bias </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007988-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007988-sec-0023">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007988-sec-0113">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD007988-sec-0023"></div> <section id="CD007988-sec-0024"> <h3 class="title" id="CD007988-sec-0024">Description of the condition</h3> <p>Asthma is a chronic inflammatory disorder of the airways, affecting an estimated 300 million people worldwide (<a href="./references#CD007988-bbs2-0181" title="Global Initiative for Asthma(GINA) . Global Strategy for Asthma Management and Prevention: 2012 Update. http://www.ginasthma.org/2012. ">GINA 2012</a>). The prevalence of asthma in adults is up to 10% in developed countries, and is currently rising (<a href="./references#CD007988-bbs2-0153" title="AsherMI , MontefortS , BjörksténB , LaiCKW , StrachanDP , WeilandSK , et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross‐sectional surveys. Lancet2006;368(9537):733‐43. ">Asher 2006</a>; <a href="./references#CD007988-bbs2-0157" title="BramanSS . The global burden of asthma. Chest2006;130(1 Suppl):4S‐12S. ">Braman 2006</a>; <a href="./references#CD007988-bbs2-0201" title="MasoliM , FabianD , HoltS , BeasleyR . The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy2004;59(5):469‐78. ">Masoli 2004</a>). Despite being a common chronic disease, it does not rank among the 15 first projected causes of mortality or disability‐adjusted life years (<a href="./references#CD007988-bbs2-0202" title="MathersCD , LoncarD . Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine2006;3(11):e442. ">Mathers 2006</a>). Nevertheless, asthma places a substantial burden on affected people and healthcare systems, with morbidity, mortality, and economic burdens that have been increasing during the last 40 years (<a href="./references#CD007988-bbs2-0157" title="BramanSS . The global burden of asthma. Chest2006;130(1 Suppl):4S‐12S. ">Braman 2006</a>). </p> <p>In order to achieve effective asthma control, the Global Initiative for Asthma (GINA) has been providing, since 2002, an evidence‐based global strategy for asthma management and prevention (<a href="./references#CD007988-bbs2-0181" title="Global Initiative for Asthma(GINA) . Global Strategy for Asthma Management and Prevention: 2012 Update. http://www.ginasthma.org/2012. ">GINA 2012</a>). However, despite the existence of effective therapies and the development of evidence‐based guidelines, there are still significant practice variations and gaps between recommended care and current practice (<a href="./references#CD007988-bbs2-0191" title="KlompH , LawsonJA , CockcroftDW , ChanBT , CascagnetteP , GanderL , et al. Examining asthma quality of care using a population‐based approach. CMAJ: Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne2008;178(8):1013‐21. ">Klomp 2008</a>; <a href="./references#CD007988-bbs2-0232" title="VermeirePA , RabeKF , SorianoJB , MaierWC . Asthma control and differences in management practices across seven European countries. Respiratory Medicine2002;96(3):142‐9. ">Vermeire 2002</a>). Asthma could be controlled, but its management remains suboptimal (<a href="./references#CD007988-bbs2-0199" title="LeuppiJD , Steurer‐SteyC , PeterM , ChhajedPN , WildhaberJH , SpertiniF . Asthma control in Switzerland: a general practitioner based survey. Current Medical Research and Opinion2006;22(11):2159‐66. ">Leuppi 2006</a>; <a href="./references#CD007988-bbs2-0232" title="VermeirePA , RabeKF , SorianoJB , MaierWC . Asthma control and differences in management practices across seven European countries. Respiratory Medicine2002;96(3):142‐9. ">Vermeire 2002</a>). </p> <p>The difficulties in asthma management are multiple, including poor implementation of treatment guidelines, suboptimal patient education and self‐management, poor patient adherence to treatment and lifestyle modifications, neglect of preventive care, and lack of co‐ordination between healthcare providers, among others (<a href="./references#CD007988-bbs2-0196" title="LatryP , PinetM , LabatA , MagandJP , PeterC , RobinsonP , et al. Adherence to anti‐inflammatory treatment for asthma in clinical practice in France. Clinical Therapeutics2008;30(6):1058‐68. ">Latry 2008</a>; <a href="./references#CD007988-bbs2-0206" title="MäkinenS , SuominenT , LauriS . What asthma patients know about their illness and its treatment. Clinical Nurse Specialist1999;13(6):277‐82. ">Mäkinen 1999</a>; <a href="./references#CD007988-bbs2-0215" title="PachecoY , ZureikM , DussoptC , ThirietC . [Patient knowledge of asthma: results of a national survey in pneumology]. Revue De Pneumologie Clinique1999;55(6):353‐63. ">Pacheco 1999</a>; <a href="./references#CD007988-bbs2-0232" title="VermeirePA , RabeKF , SorianoJB , MaierWC . Asthma control and differences in management practices across seven European countries. Respiratory Medicine2002;96(3):142‐9. ">Vermeire 2002</a>). A variety of individual interventions have been used to address these issues and systematically assessed. For instance, a Cochrane review showed that self‐management programmes in adult asthmatics reduced healthcare utilisation, the number of days off work or school, nocturnal asthma, and improved quality of life (<a href="./references#CD007988-bbs2-0180" title="GibsonPG , PowellH , CoughlanJ , WilsonA , AbramsonMJ , HaywoodP , et al. Self‐management education and regular practitioner review for adults with asthma. Cochrane Database of Systematic Reviews2002, Issue 3. [DOI: 10.1002/14651858.CD001117] ">Gibson 2003</a>). In contrast, limited patient education (information only) did not (<a href="./references#CD007988-bbs2-0179" title="GibsonPG , PowellH , CoughlanJ , WilsonA , HensleyMJ , AbramsonMJ , et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database of Systematic Reviews2002, Issue 2. [DOI: 10.1002/14651858.CD001005] ">Gibson 2002</a>). Similarly, two other systematic reviews examining the effectiveness of written asthma action plans did not find evidence of benefit (<a href="./references#CD007988-bbs2-0220" title="PowellH , GibsonPG . Options for self‐management education for adults with asthma. Cochrane Database of Systematic Reviews2003, Issue 3. [DOI: 10.1002/14651858.CD004107] ">Powell 2003</a>; <a href="./references#CD007988-bbs2-0228" title="ToelleBG , RamFSF . Written individualised management plans for asthma in children and adults. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD002171] ">Toelle 2004</a>). Nevertheless, given that the included studies were small and of low power, experts still recommend the use of written action plans (<a href="./references#CD007988-bbs2-0181" title="Global Initiative for Asthma(GINA) . Global Strategy for Asthma Management and Prevention: 2012 Update. http://www.ginasthma.org/2012. ">GINA 2012</a>; <a href="./references#CD007988-bbs2-0207" title="[noauthor] . National Asthma Education and Prevention Program Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma‐Summary Report. Journal of Allergy and Clinical Immunology2007;120(5 Suppl):S94‐S138. ">NAEPP 2007</a>). Finally, provider level interventions such as continuing medical education, reminder systems, or audit with feedback yielded inconsistent results across chronic diseases (<a href="./references#CD007988-bbs2-0161" title="DavisDA , ThomsonMA , OxmanAD , HaynesRB . Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA1995;274(9):700‐5. ">Davis 1995</a>; <a href="./references#CD007988-bbs2-0162" title="DavisD , O'BrienMA , FreemantleN , WolfFM , MazmanianP , Taylor‐VaiseyA . Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?. JAMA1999;282(9):867‐74. ">Davis 1999</a>; <a href="./references#CD007988-bbs2-0236" title="WeingartenSR , HenningJM , BadamgaravE , KnightK , HasselbladV , GanoA , et al. Interventions used in disease management programmes for patients with chronic illness‐‐‐which ones work? Meta‐analysis of published reports. BMJ2002;325(7370):925. ">Weingarten 2002</a>). The combination of all these types of interventions is proposed in chronic disease management programmes. </p> </section> <section id="CD007988-sec-0025"> <h3 class="title" id="CD007988-sec-0025">Description of the intervention</h3> <p>Chronic disease management (CDM) was developed during the 1990s as a means of reorganising healthcare systems and medical treatment for chronic diseases such as heart failure, diabetes, depression, and chronic lung diseases. Its purpose is to enhance the quality and cost‐effectiveness of care for chronic diseases. CDM is centred on patients' needs, fosters the co‐ordination and integration of health services provided by various professionals who should work together (multidisciplinary care), and emphasizes patients’ self‐management as well as education and empowerment. CDM is also based on formal evidence of effectiveness and promotes continuous improvement processes through quality control (<a href="./references#CD007988-bbs2-0165" title="Definition of disease management. Disease Management Association of America. Available at http://www.dmaa.org/phi_definition.asp. Accessed on 20 December 2009. ">DMAA Definitions 2009</a>; <a href="./references#CD007988-bbs2-0170" title="EllrodtG , CookDJ , LeeJ , ChoM , HuntD , WeingartenS . Evidence‐based disease management. JAMA1997;278(20):1687‐92. ">Ellrodt 1997</a>; <a href="./references#CD007988-bbs2-0174" title="EpsteinRS , SherwoodLM . From outcomes research to disease management: a guide for the perplexed. Annals of Internal Medicine1996;124(9):832‐7. ">Epstein 1996</a>; <a href="./references#CD007988-bbs2-0176" title="FaxonDP , SchwammLH , PasternakRC , PetersonED , McNeilBJ , BufalinoVincent , et al. Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. Circulation2004;109(21):2651‐4. ">Faxon 2004</a>; <a href="./references#CD007988-bbs2-0186" title="HunterDJ , FairfieldG . Disease management. BMJ (Clinical research ed.)1997;315(7099):50‐3. ">Hunter 1997</a>; <a href="./references#CD007988-bbs2-0190" title="KestelootK . Disease management. A new technology in need of critical assessment. International Journal of Technology Assessment in Health Care1999;15(3):506‐19. ">Kesteloot 1999</a>; <a href="./references#CD007988-bbs2-0218" title="PilnickA , DingwallR , StarkeyK . Disease management: definitions, difficulties and future directions. Bulletin of the World Health Organization2001;79(8):755‐63. ">Pilnick 2001</a>; <a href="./references#CD007988-bbs2-0236" title="WeingartenSR , HenningJM , BadamgaravE , KnightK , HasselbladV , GanoA , et al. Interventions used in disease management programmes for patients with chronic illness‐‐‐which ones work? Meta‐analysis of published reports. BMJ2002;325(7370):925. ">Weingarten 2002</a>). </p> <p>Several definitions of CDM, which differ by the number and variety of elements that they integrate, have been published (<a href="./references#CD007988-bbs2-0165" title="Definition of disease management. Disease Management Association of America. Available at http://www.dmaa.org/phi_definition.asp. Accessed on 20 December 2009. ">DMAA Definitions 2009</a>; <a href="./references#CD007988-bbs2-0170" title="EllrodtG , CookDJ , LeeJ , ChoM , HuntD , WeingartenS . Evidence‐based disease management. JAMA1997;278(20):1687‐92. ">Ellrodt 1997</a>; <a href="./references#CD007988-bbs2-0174" title="EpsteinRS , SherwoodLM . From outcomes research to disease management: a guide for the perplexed. Annals of Internal Medicine1996;124(9):832‐7. ">Epstein 1996</a>; <a href="./references#CD007988-bbs2-0176" title="FaxonDP , SchwammLH , PasternakRC , PetersonED , McNeilBJ , BufalinoVincent , et al. Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. Circulation2004;109(21):2651‐4. ">Faxon 2004</a>; <a href="./references#CD007988-bbs2-0186" title="HunterDJ , FairfieldG . Disease management. BMJ (Clinical research ed.)1997;315(7099):50‐3. ">Hunter 1997</a>; <a href="./references#CD007988-bbs2-0190" title="KestelootK . Disease management. A new technology in need of critical assessment. International Journal of Technology Assessment in Health Care1999;15(3):506‐19. ">Kesteloot 1999</a>; <a href="./references#CD007988-bbs2-0218" title="PilnickA , DingwallR , StarkeyK . Disease management: definitions, difficulties and future directions. Bulletin of the World Health Organization2001;79(8):755‐63. ">Pilnick 2001</a>; <a href="./references#CD007988-bbs2-0236" title="WeingartenSR , HenningJM , BadamgaravE , KnightK , HasselbladV , GanoA , et al. Interventions used in disease management programmes for patients with chronic illness‐‐‐which ones work? Meta‐analysis of published reports. BMJ2002;325(7370):925. ">Weingarten 2002</a>). In addition, the American Heart Association’s Disease Management Taxonomy Writing Group developed a system of classification intended to help categorise and compare disease management programmes (<a href="./references#CD007988-bbs2-0194" title="KrumholzHM , CurriePM , RiegelB , PhillipsCO , PetersonED , SmithR , et al. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation2006;114(13):1432‐45. ">Krumholz 2006</a>). Recently, to facilitate the understanding and communication about the concept of CDM, <a href="./references#CD007988-bbs2-0223" title="SchrijversG . Disease management: a proposal for a new definition. International Journal of Integrated Care2009;9:e06. ">Schrijvers 2009</a> proposed a tentative definition of chronic disease management based on the elements found in the literature: "[CDM] consists of a group of coherent interventions designed to prevent or manage one or more chronic conditions using a systematic multidisciplinary approach potentially employing multiple treatment modalities. The goal of chronic disease management is to identify persons at risk for one or more chronic conditions, to promote self‐management by patients and to address the illness or conditions with maximum clinical outcome, effectiveness and efficiency regardless of treatment setting(s) or typical reimbursement patterns” (<a href="./references#CD007988-bbs2-0223" title="SchrijversG . Disease management: a proposal for a new definition. International Journal of Integrated Care2009;9:e06. ">Schrijvers 2009</a>). Because CDM programmes are adapted to the regional healthcare, social, and political contexts, they vary in terms of treatment modalities, frequency, intensity, and duration. Nevertheless, several systematic reviews have shown that CDM programmes are effective, at least for some outcomes and some chronic diseases such as diabetes (<a href="./references#CD007988-bbs2-0168" title="EggintonJS , RidgewayJL , ShahND , BalasubramaniamS , EmmanuelJR , ProkopLJ , et al. Care management for Type 2 diabetes in the United States: a systematic review and meta‐analysis. BMC Health Services Research2012;12:72. [PUBMED: 22439920] ">Egginton 2012</a>; <a href="./references#CD007988-bbs2-0169" title="ElissenAM , SteutenLM , LemmensLC , DrewesHW , LemmensKM , MeeuwissenJA , et al. Meta‐analysis of the effectiveness of chronic care management for diabetes: investigating heterogeneity in outcomes. Journal of Evaluation in Clinical Practice2013;19(5):753‐62. [PUBMED: 22372830] ">Elissen 2013</a>; <a href="./references#CD007988-bbs2-0192" title="KnightK , BadamgaravE , HenningJM , HasselbladV , GanoAD , OfmanJJ , et al. A systematic review of diabetes disease management programs. The American Journal of Managed Care2005;11(4):242‐50. ">Knight 2005</a>; <a href="./references#CD007988-bbs2-0212" title="NorrisSL , NicholsPJ , CaspersenCJ , GlasgowRE , EngelgauMM , JackL , et al. The effectiveness of disease and case management for people with diabetes. A systematic review. American Journal of Preventive Medicine2002;22(4 Suppl):15‐38. ">Norris 2002</a>; <a href="./references#CD007988-bbs2-0219" title="PimouguetC , LeGoffM , ThiebautR , DartiguesJF , HelmerC . Effectiveness of disease‐management programs for improving diabetes care: a meta‐analysis. CMAJ: Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne2011;183(2):E115‐27. [PUBMED: 21149524] ">Pimouguet 2011</a>), depression (<a href="./references#CD007988-bbs2-0154" title="BadamgaravE , WeingartenSR , HenningJM , KnightK , HasselbladV , GanoA , et al. Effectiveness of disease management programs in depression: a systematic review. The American Journal of Psychiatry2003;160(12):2080‐90. ">Badamgarav 2003</a>; <a href="./references#CD007988-bbs2-0210" title="Neumeyer‐GromenA , LampertT , StarkK , KallischniggG . Disease management programs for depression: a systematic review and meta‐analysis of randomized controlled trials. Medical Care2004;42(12):1211‐21. ">Neumeyer‐Gromen 2004</a>), chronic heart failure (<a href="./references#CD007988-bbs2-0183" title="GohlerA , JanuzziJL , WorrellSS , OsterzielKJ , GazelleGS , DietzR , et al. A systematic meta‐analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. Journal of Cardiac Failure2006;12(7):554‐67. [PUBMED: 16952790] ">Gohler 2006</a>; <a href="./references#CD007988-bbs2-0184" title="GonsethJ , Guallar‐CastillónP , BanegasJR , Rodríguez‐ArtalejoF . The effectiveness of disease management programmes in reducing hospital re‐admission in older patients with heart failure: a systematic review and meta‐analysis of published reports. European Heart Journal2004;25(18):1570‐95. ">Gonseth 2004</a>; <a href="./references#CD007988-bbs2-0203" title="McAlisterFA , LawsonFM , TeoKK , ArmstrongPW . A systematic review of randomized trials of disease management programs in heart failure. The American Journal of Medicine2001;110(5):378‐84. ">McAlister 2001</a>; <a href="./references#CD007988-bbs2-0222" title="RoccaforteR , DemersC , BaldassarreF , TeoKK , YusufS . Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta‐analysis. European Journal of Heart Failure2005;7(7):1133‐44. ">Roccaforte 2005</a>), and chronic obstructive pulmonary disease (COPD) (<a href="./references#CD007988-bbs2-0152" title="AdamsSG , SmithPK , AllanPF , AnzuetoA , PughJA , CornellJE . Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Archives of Internal Medicine2007;167(6):551‐61. [PUBMED: 17389286] ">Adams 2007</a>; <a href="./references#CD007988-bbs2-0193" title="KruisAL , SmidtN , AssendelftWJ , GusseklooJ , BolandMR , Rutten‐van MolkenM , et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews2013;10:CD009437. [PUBMED: 24108523] ">Kruis 2013</a>; <a href="./references#CD007988-bbs2-0198" title="LemmensKM , LemmensLC , BoomJH , DrewesHW , MeeuwissenJA , SteutenLM , et al. Chronic care management for patients with COPD: a critical review of available evidence. Journal of Evaluation in Clinical Practice2013;19(5):734‐52. [PUBMED: 22133473] ">Lemmens 2013</a>; <a href="./references#CD007988-bbs2-0211" title="NiesinkA , TrappenburgJCA , deWeert‐vanOGH , LammersJWJ , VerheijTJM , SchrijversAJP . Systematic review of the effects of chronic disease management on quality‐of‐life in people with chronic obstructive pulmonary disease. Respiratory Medicine2007;101(11):2233‐9. ">Niesink 2007</a>; <a href="./references#CD007988-bbs2-0216" title="Peytremann‐BridevauxI , StaegerP , BridevauxPO , GhaliWA , BurnandB . Effectiveness of chronic obstructive pulmonary disease‐management programs: systematic review and meta‐analysis. The American Journal of Medicine2008;121(5):433‐43.e4. ">Peytremann‐Bridevaux 2008</a>), or across chronic conditions (<a href="./references#CD007988-bbs2-0163" title="deBruinSR , HeijinkR , LemmensLC , StruijsJN , BaanCA . Impact of disease management programs on healthcare expenditures for patients with diabetes, depression, heart failure or chronic obstructive pulmonary disease: a systematic review of the literature. Health Policy2011;101(2):105‐21. [PUBMED: 21592607] ">de Bruin 2011</a>; <a href="./references#CD007988-bbs2-0213" title="OfmanJJ , BadamgaravE , HenningJM , KnightK , GanoAD , LevanRK , et al. Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. The American Journal of Medicine2004;117(3):182‐92. ">Ofman 2004</a>; <a href="./references#CD007988-bbs2-0214" title="OuwensM , WollersheimH , HermensR , HulscherM , GrolR . Integrated care programmes for chronically ill patients: a review of systematic reviews. International Journal for Quality in Health Care2005;17(2):141‐6. ">Ouwens 2005</a>; <a href="./references#CD007988-bbs2-0229" title="TsaiAC , MortonSC , MangioneCM , KeelerEB . A meta‐analysis of interventions to improve care for chronic illnesses. The American Journal of Managed Care2005;11(8):478‐88. [PUBMED: 16095434] ">Tsai 2005</a>). As such, they are supported by an increasing number of healthcare systems (<a href="./references#CD007988-bbs2-0158" title="BusseR . Disease management programs In Germany's statutory health insurance system. Health Affairs2004;23(3):56‐67. ">Busse 2004</a>; <a href="./references#CD007988-bbs2-0182" title="GogovorA , SavoieM , MorideY , KrelenbaumM , MontagueT . Contemporary disease management in Quebec. Healthcare Quarterly2008;11(1):30‐7. ">Gogovor 2008</a>; <a href="./references#CD007988-bbs2-0205" title="MontagueTJ , GogovorA , KrelenbaumM . Time for chronic disease care and management. The Canadian Journal of Cardiology2007;23(12):971‐5. ">Montague 2007</a>; <a href="./references#CD007988-bbs2-0224" title="SteutenL , PalmerS , VrijhoefB , vanMerodeF , SpreeuwenbergC , SeverensH . Cost‐utility of a disease management program for patients with asthma. International Journal of Technology Assessment in Health Care2007;23(2):184‐91. ">Steuten 2007</a>; <a href="./references#CD007988-bbs2-0226" title="StockSAK , RedaelliM , LauterbachKW . Population‐based disease management in the German statutory health insurance: implementation and preliminary results. Disease Management and Health Outcomes2006;14(1):5‐12. ">Stock 2006</a>) and have been implemented throughout Northern American and European countries during the past decade (<a href="./references#CD007988-bbs2-0209" title="State Disease Management Program Descriptions. National Conference of State Legislature. Available at http://www.ncsl.org/programs/health/StateDiseasemgmt1.htm. ">NCSL DMP descriptions</a>). </p> </section> <section id="CD007988-sec-0026"> <h3 class="title" id="CD007988-sec-0026">Why it is important to do this review</h3> <p>Asthma presents all characteristics described as mandatory for CDM suitability (<a href="./references#CD007988-bbs2-0204" title="MechanicRE . Disease Management: A Promising Approach for Health Care Purchasers. Washington, DC: National Health Care Purchasing Institute 2002. Available at http://www.futurevision.com.ua/nhcpi/files/3df220809e247.pdf. Accessed on 10 May 2009. ">Mechanic 2002</a>; <a href="./references#CD007988-bbs2-0231" title="Velasco‐GarridoM , BusseR , HisashigeA . Are disease management programmes (DMPs) effective in improving quality of care for people with chronic conditions?. Copenhagen, WHO Regional Office for Europe (Health Evidence Network report) Available at http://www.euro.who.int/document/e82974.pdf. Accessed 10 May 20092003. ">Velasco‐Garrido 2003</a>). Indeed, asthma CDM programmes have yielded positive results in some studies and are considered a promising way to improve asthma management and reduce costs (<a href="./references#CD007988-bbs2-0156" title="Blaiss MichaelS . Asthma disease management: a critical analysis. Annals of Allergy, Asthma &amp; Immunology2005;95(5 Suppl 1):S10‐6. ">Blaiss 2005</a>; <a href="./references#CD007988-bbs2-0166" title="DurbinCGJr . The role of the respiratory care practitioner in the continuum of disease management. Respiratory Care1997;42:159‐68. ">Durbin 1997</a>; <a href="./references#CD007988-bbs2-0225" title="SteutenL , LemmensK , VrijhoefB . Health technology assessment of asthma disease management programs. Current Opinion in Allergy and Clinical Immunology2007;7(3):242‐8. ">Steuten 2007a</a>). Still, the effectiveness of CDM for adults with asthma has yet to be systematically and comprehensively assessed. One systematic review evaluating CDM programmes for patients with asthma found that these programmes reduced resource utilisation and improved some aspects of self‐management and organisation of care, but had almost no impact on asthma symptoms and lung function (<a href="./references#CD007988-bbs2-0225" title="SteutenL , LemmensK , VrijhoefB . Health technology assessment of asthma disease management programs. Current Opinion in Allergy and Clinical Immunology2007;7(3):242‐8. ">Steuten 2007a</a>). However, it only included studies published between December 2005 and December 2006 and considered both adults and children with asthma. The authors also showed that while process and outcome measures were more appropriately chosen than before, structure indicators were lacking. Two other systematic reviews published in 2009 (<a href="./references#CD007988-bbs2-0197" title="LemmensKM , NieboerAP , HuijsmanR . A systematic review of integrated use of disease‐management interventions in asthma and COPD. Respiratory Medicine2009;103(5):670‐91. [PUBMED: 19155168] ">Lemmens 2009</a>; <a href="./references#CD007988-bbs2-0200" title="MaciejewskiML , ChenSY , AuDH . Adult asthma disease management: an analysis of studies, approaches, outcomes, and methods. Respiratory Care2009;54(7):878‐86. [PUBMED: 19558739] ">Maciejewski 2009</a>) provided further information. The <a href="./references#CD007988-bbs2-0197" title="LemmensKM , NieboerAP , HuijsmanR . A systematic review of integrated use of disease‐management interventions in asthma and COPD. Respiratory Medicine2009;103(5):670‐91. [PUBMED: 19155168] ">Lemmens 2009</a> review showed that CDM programmes targeting adults with asthma or COPD improved quality of life and decreased the risk of hospitalisation, especially when the interventions included three components, but did not have any effect on emergency visits. The authors of the other review on CDM programmes, targeting only adults with asthma, decided not to conduct meta‐analyses because of heterogeneity and missing information; they concluded that the quality of studies was not optimal and that it was not possible to decide whether CDM would or would not be beneficial to patients with asthma (<a href="./references#CD007988-bbs2-0200" title="MaciejewskiML , ChenSY , AuDH . Adult asthma disease management: an analysis of studies, approaches, outcomes, and methods. Respiratory Care2009;54(7):878‐86. [PUBMED: 19558739] ">Maciejewski 2009</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007988-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007988-sec-0027">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007988-sec-0117">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007988-sec-0027"></div> <section id="CD007988-sec-0028"> <h3 class="title" id="CD007988-sec-0028">Primary objective</h3> <p>To assess the effectiveness of chronic disease management programmes for adults with asthma. </p> </section> <section id="CD007988-sec-0029"> <h3 class="title" id="CD007988-sec-0029">Secondary objectives</h3> <p>To assess the effectiveness of chronic disease management programmes for adults with asthma according to the intensity of the intervention (e.g., more intensive versus minimal interventions, in terms of number of intervention components and types of components, such as mainly centred on the patient versus on healthcare professionals). </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007988-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007988-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007988-sec-0120">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007988-sec-0030"></div> <section id="CD007988-sec-0031"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007988-sec-0032"> <h4 class="title">Types of studies</h4> <p>Eligible studies were randomised controlled trials (RCTs), non‐randomised controlled trials (NRCTs), controlled before‐after studies (CBAs), and interrupted time series studies (ITSs), allocating patients or clusters. According to the guidance from the Effective Practice and Organisation of Care (EPOC) Review group (<a href="./references#CD007988-bbs2-0171" title="EffectivePractice , Organisation of Care(EPOC) . What study designs should be included in an EPOC review and what should they be called? EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services 2013. Available at: http://epocoslo.cochrane.org/epoc‐specific‐resources‐review‐authors. Accessed on 18 May 2014. ">EPOC 2013</a>), CBA studies were eligible only if the pre‐ and post‐intervention periods for the study and control sites were the same; if the study and control sites were comparable with respect to the dominant reimbursement system, level of care, setting of care, and academic status; and if there were a minimum of two interventions and two control sites. ITS studies were eligible only if there was a clear, time‐defined beginning of the intervention and if there was a minimum of three measurement points available before and after the intervention. </p> <p>The rationale for including study types other than RCTs was that it can be difficult to implement RCTs assessing complex disease management programmes. Additionally, this is a relatively new research area with few RCTs. </p> </section> <section id="CD007988-sec-0033"> <h4 class="title">Types of participants</h4> <p>We included adult participants (over 16 years of age) with a diagnosis of asthma. We excluded studies in which patients with other significant pulmonary chronic disease (like moderate or severe COPD or bronchiectasis) represented a significant proportion of participants, unless subgroup analysis was available. In the same way, trials including both adults and children were included only if the majority of participants were over 16 years or if the adult subgroup was analysed independently. </p> </section> <section id="CD007988-sec-0034"> <h4 class="title">Types of interventions</h4> <p>Based on several definitions of disease management (<a href="./references#CD007988-bbs2-0165" title="Definition of disease management. Disease Management Association of America. Available at http://www.dmaa.org/phi_definition.asp. Accessed on 20 December 2009. ">DMAA Definitions 2009</a>; <a href="./references#CD007988-bbs2-0170" title="EllrodtG , CookDJ , LeeJ , ChoM , HuntD , WeingartenS . Evidence‐based disease management. JAMA1997;278(20):1687‐92. ">Ellrodt 1997</a>; <a href="./references#CD007988-bbs2-0174" title="EpsteinRS , SherwoodLM . From outcomes research to disease management: a guide for the perplexed. Annals of Internal Medicine1996;124(9):832‐7. ">Epstein 1996</a>; <a href="./references#CD007988-bbs2-0176" title="FaxonDP , SchwammLH , PasternakRC , PetersonED , McNeilBJ , BufalinoVincent , et al. Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. Circulation2004;109(21):2651‐4. ">Faxon 2004</a>; <a href="./references#CD007988-bbs2-0186" title="HunterDJ , FairfieldG . Disease management. BMJ (Clinical research ed.)1997;315(7099):50‐3. ">Hunter 1997</a>; <a href="./references#CD007988-bbs2-0190" title="KestelootK . Disease management. A new technology in need of critical assessment. International Journal of Technology Assessment in Health Care1999;15(3):506‐19. ">Kesteloot 1999</a>; <a href="./references#CD007988-bbs2-0218" title="PilnickA , DingwallR , StarkeyK . Disease management: definitions, difficulties and future directions. Bulletin of the World Health Organization2001;79(8):755‐63. ">Pilnick 2001</a>; <a href="./references#CD007988-bbs2-0236" title="WeingartenSR , HenningJM , BadamgaravE , KnightK , HasselbladV , GanoA , et al. Interventions used in disease management programmes for patients with chronic illness‐‐‐which ones work? Meta‐analysis of published reports. BMJ2002;325(7370):925. ">Weingarten 2002</a>), we considered the following five criteria for our operational definition of CDM: </p> <p> <ol id="CD007988-list-0001"> <li> <p>at least one organisational component (i.e., elements that interfere with the care process or that aim to improve continuity of care) targeting patients (<a href="./references#CD007988-bbs2-0225" title="SteutenL , LemmensK , VrijhoefB . Health technology assessment of asthma disease management programs. Current Opinion in Allergy and Clinical Immunology2007;7(3):242‐8. ">Steuten 2007a</a>; <a href="./references#CD007988-bbs2-0236" title="WeingartenSR , HenningJM , BadamgaravE , KnightK , HasselbladV , GanoA , et al. Interventions used in disease management programmes for patients with chronic illness‐‐‐which ones work? Meta‐analysis of published reports. BMJ2002;325(7370):925. ">Weingarten 2002</a>); </p> </li> <li> <p>at least one organisational component targeting healthcare professionals (e.g., physicians, nurses, etc.), the healthcare system, or both; </p> </li> <li> <p>presence of a patient education or self‐management support component, or both;</p> </li> <li> <p>active involvement of two or more healthcare professionals in patient care; and</p> </li> <li> <p>minimum duration of three months (or 12 weeks) for at least one component.</p> </li> </ol> </p> <p>Therefore, we only included CDM programmes that entirely met the above operational definition of chronic disease management (that is, all five criteria are compulsory). Below are listed the types of components that are usually proposed in CDM programmes, adapted to asthma patients. They directly relate to the above‐mentioned five criteria. </p> <p>1. At least one organisational component targeting patients (each of the following was considered as an independent component): </p> <p> <ul id="CD007988-list-0002"> <li> <p>case management (defined as explicit allocation of co‐ordination tasks to a case manager or a small team who takes responsibility for guiding the patient through the care process in the most efficient, effective, and acceptable way); </p> </li> <li> <p>structured follow‐up (e.g., telephone calls, regular clinic visits, etc.) or encouragement for regular follow‐up; </p> </li> <li> <p>home or outreach visits;</p> </li> <li> <p>discharge planning in the case of hospitalisation;</p> </li> <li> <p>advice or assistance, or both, if needed (e.g., a telephone hotline);</p> </li> <li> <p>smoking cessation programmes recommended or proposed, or both; and</p> </li> <li> <p>other (other components deemed compatible by all the review authors).</p> </li> </ul> </p> <p>2. At least one organisational component targeting primarily healthcare professionals (for example physicians, nurses, etc.) or the healthcare system, or both, such as: </p> <p> <ul id="CD007988-list-0003"> <li> <p>explicit teamwork and collaborative processes between healthcare providers;</p> </li> <li> <p>physicians’ education and training (any format) or other healthcare professionals’ education and training, or both; </p> </li> <li> <p>other quality improvement processes (e.g., reminder systems, clinical pathways, routine reporting, feedback loops, etc.); </p> </li> <li> <p>integration of care (i.e., continuity of care between primary, secondary, and tertiary care); </p> </li> <li> <p>financial incentives;</p> </li> <li> <p>information technology (e.g., computerised medical records, reminders or prompts, etc.); </p> </li> <li> <p>explicit use of evidence‐based medicine supports (e.g., use of evidence‐based clinical practice guidelines, etc.); </p> </li> <li> <p>process and outcome measurements (at the patient level);</p> </li> <li> <p>evaluation of CDM programmes (at the group level); and</p> </li> <li> <p>other (other components deemed compatible by all the reviews authors).</p> </li> </ul> </p> <p>3. Presence of a patient education or self‐management support component, or both. Patient education was defined as giving the patients information (materials, instructions, or both) regarding: </p> <p> <ul id="CD007988-list-0004"> <li> <p>asthma;</p> </li> <li> <p>management of the disease, its exacerbations, or both;</p> </li> <li> <p>prevention of exacerbations (trigger recognition and reduction strategies);</p> </li> <li> <p>smoking cessation;</p> </li> <li> <p>exercise or physical activity.</p> </li> </ul> </p> <p>The types of educational sessions included, for example:</p> <p> <ul id="CD007988-list-0005"> <li> <p>distribution of published or printed material;</p> </li> <li> <p>educational groups or meetings;</p> </li> <li> <p>one‐on‐one educational sessions during visits (physician, nurses, etc.).</p> </li> </ul> </p> <p>Self‐management support was defined as helping patients acquire the skills and knowledge to manage their own illnesses, providing self‐management tools, and routinely assessing their problems and accomplishments (<a href="./references#CD007988-bbs2-0214" title="OuwensM , WollersheimH , HermensR , HulscherM , GrolR . Integrated care programmes for chronically ill patients: a review of systematic reviews. International Journal for Quality in Health Care2005;17(2):141‐6. ">Ouwens 2005</a>). The types of self‐management support included, for example: </p> <p> <ul id="CD007988-list-0006"> <li> <p>the availability of an action plan;</p> </li> <li> <p>so‐called supervised reinforcement sessions;</p> </li> <li> <p>regular checks of inhalation technique.</p> </li> </ul> </p> <p>4. Two or more healthcare professionals actively involved in the patient care, such as: </p> <p> <ul id="CD007988-list-0007"> <li> <p>general or family practitioners (GPs), primary care physicians, and general internists;</p> </li> <li> <p>pulmonary care physicians;</p> </li> <li> <p>respiratory care nurses (nurses with training in asthma management);</p> </li> <li> <p>non‐specialised nurses;</p> </li> <li> <p>physiotherapists;</p> </li> <li> <p>pharmacists; and</p> </li> <li> <p>other healthcare professionals (for example social workers).</p> </li> </ul> </p> <p>5. Minimal duration of three months (12 weeks) for at least one component.</p> <p>CDM programmes targeting chronic diseases require long lasting interventions, and should not be merely considered as another treatment modality but rather as a new way to organise care implemented from a long‐term perspective. Therefore, they needed to have at least one component from criteria one to three that lasted three months or more (arbitrary cut‐off point). </p> <p>We compared CDM to standard care (varying from usual care to usual care including limited CDM components). </p> </section> <section id="CD007988-sec-0035"> <h4 class="title">Types of outcome measures</h4> <p>Throughout the text, we use the term outcome in its broad sense to refer to the notion of dependent variable. Under that term, we considered clinically relevant effect measures (such as patient outcomes), process of care and intermediate measures, as well as structure indicators. These were based and adapted from a consensus of clinically relevant outcomes of an asthma patient management model (<a href="./references#CD007988-bbs2-0159" title="ClarkNM , Starr‐SchneidkrautNJ . Management of asthma by patients and families. American Journal of Respiratory and Critical Care Medicine1994;149(2 Pt 2):S54‐66; discussion S67‐8. ">Clark 1994</a>). Indicators relating to the implementation of CDM programmes, per se, were not considered. We divided our outcomes into two main groups: organisational and patient level outcomes. The list of possible outcomes, as well as the 10 outcomes selected as primary outcomes (specified in brackets) that were considered in the analyses, are shown below. We included 7 of these 10 primary outcomes in the <a href="./full#CD007988-tbl-0001">summary of findings Table for the main comparison</a>, based on their clinical importance: quality of life, hospitalisation, emergency or unscheduled visits, asthma exacerbations, self‐efficacy, asthma severity, and days off school or work absences. </p> <section id="CD007988-sec-0036"> <h5 class="title">Organisational level outcomes</h5> <p> <ul id="CD007988-list-0008"> <li> <p>Organisation of care outcomes: participation rate for CDM programme; healthcare professionals’ satisfaction with programme. </p> </li> </ul> <ul id="CD007988-list-0009"> <li> <p>Process outcomes: use of an action plan (primary); compliance with treatment schedule; prescription of inhaled corticosteroids; check of appropriate inhalation techniques; and smoking cessation advice or support, or both. </p> </li> </ul> <ul id="CD007988-list-0010"> <li> <p>Healthcare utilisation outcomes: asthma‐related or all‐cause hospitalisation, or both, defined as any inpatient hospital stay (primary); asthma‐related or all‐cause unscheduled visits, or both, defined as urgent visits to hospital emergency departments (ED) or unscheduled physicians visits (primary); GP visits, defined as routine (scheduled) ambulatory care visits to a GP or family physician; and healthcare costs (direct and indirect, if available). </p> </li> </ul> </p> </section> <section id="CD007988-sec-0037"> <h5 class="title">Patient level outcomes</h5> <p> <ul id="CD007988-list-0011"> <li> <p>Quality of life: an asthma‐specific quality of life instrument (primary) such as the St‐George Respiratory Questionnaire (<a href="./references#CD007988-bbs2-0188" title="JonesPW , QuirkFH , BaveystockCM . The St George's Respiratory Questionnaire. Respiratory Medicine1991;85 Suppl B:25‐31; discussion 33‐7. ">Jones 1991</a>), Living with Asthma Questionnaire (LWAQ) (<a href="./references#CD007988-bbs2-0187" title="HylandME , FinnisS , IrvineSH . A scale for assessing quality of life in adult asthma sufferers. Journal of Psychosomatic Research1991;35(1):99‐110. ">Hyland 1991</a>), Asthma Quality of Life Questionnaire (AQLQ) (<a href="./references#CD007988-bbs2-0189" title="JuniperEF , GuyattGH , EpsteinRS , FerriePJ , JaeschkeR , HillerTK . Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax1992;47(2):76‐83. ">Juniper 1992</a>); a generic quality of life instrument such as the Short Form 36 (SF‐36) (<a href="./references#CD007988-bbs2-0234" title="WareJE , SherbourneCD . The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Medical Care1992;30(6):473‐83. ">Ware 1992</a>), SF‐12 (<a href="./references#CD007988-bbs2-0235" title="WareJ , KosinskiM , KellerSD . A 12‐Item Short‐Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care1996;34(3):220‐33. ">Ware 1996</a>), EQ‐5D (<a href="./references#CD007988-bbs2-0175" title="The EuroQol Group. EuroQol ‐ a new facility for the measurement of health‐related quality of life. Health Policy1990;16(3):199‐208. ">EuroQol Group 1990</a>), or self reported subjective health. </p> </li> </ul> <ul id="CD007988-list-0012"> <li> <p>Symptoms and activity level: asthma exacerbations (defined as prompting hospitalisation, ED visit, unscheduled medical visit, or rescue systemic glucocorticoids) (primary); asthma severity and symptoms (primary) (subjective measures that include asthma symptoms or severity scores, or both) (e.g., the Asthma Control Test (<a href="./references#CD007988-bbs2-0208" title="NathanRA , SorknessCA , KosinskiM , SchatzM , LiJT , MarcusP , et al. Development of the asthma control test: a survey for assessing asthma control. The Journal of Allergy and Clinical Immunology2004;113(1):59‐65. ">Nathan 2004</a>), the Asthma Therapy Assessment Questionnaire (ATAQ) (<a href="./references#CD007988-bbs2-0233" title="VollmerWM , MarksonLE , O'ConnorE , SanockiLL , FittermanL , BergerM , et al. Association of asthma control with health care utilization and quality of life. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1647‐52. ">Vollmer 1999</a>)); days off school or work absences (due to asthma or other causes, or both) (primary); nights disturbed by asthma (sleep interruptions due to asthma or nights with asthma symptoms); days of restricted activity; use of rescue ß2‐agonists; and all‐cause mortality. </p> </li> </ul> <ul id="CD007988-list-0013"> <li> <p>Self‐management: patients' asthma knowledge score; trigger recognition and reduction strategies; measures of self‐efficacy and self‐management (primary). </p> </li> </ul> <ul id="CD007988-list-0014"> <li> <p>Pulmonary function tests: forced expiratory volume in 1 second (FEV1); peak expiratory flow rate (PEF); a combined measure of lung function, defined as either FEV1 or PEF (primary). </p> </li> </ul> <ul id="CD007988-list-0015"> <li> <p>Patient satisfaction with care: measures of patient satisfaction (or experiences) with care (primary). </p> </li> </ul> </p> <p>To define the timing of outcomes measurements, we grouped time points in three arbitrary intervals to represent short‐term, medium‐term, and long‐term outcomes (from 0 to 6 months, 6 to 12 months, and over 12 months). </p> <p>Studies were excluded if none of the primary outcomes were reported.</p> </section> </section> </section> <section id="CD007988-sec-0038"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007988-sec-0039"> <h4 class="title">Electronic searches</h4> <p>M Fiander, Trials Search Co‐ordinator (TSC) for the EPOC review group, developed search strategies in consultation with the authors. The TSC searched the Cochrane Database of Systematic Reviews and the Database of Abstracts of Reviews of Effects (DARE) for related systematic reviews and the databases listed below for primary studies. Searches were conducted to June 2014; exact search dates for each database are included in the search strategies in <a href="./appendices#CD007988-sec-0098">Appendix 1</a>; <a href="./appendices#CD007988-sec-0099">Appendix 2</a>; <a href="./appendices#CD007988-sec-0100">Appendix 3</a>; <a href="./appendices#CD007988-sec-0101">Appendix 4</a>; <a href="./appendices#CD007988-sec-0102">Appendix 5</a>. </p> <p> <ul id="CD007988-list-0016"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), OvidSP.</p> </li> </ul> <ul id="CD007988-list-0017"> <li> <p>Cochrane EPOC Group Specialised Register (to 2012).</p> </li> </ul> <ul id="CD007988-list-0018"> <li> <p>MEDLINE In‐Process and Other Non‐Indexed Citations (1946 on), OvidSP.</p> </li> </ul> <ul id="CD007988-list-0019"> <li> <p>EMBASE (1947 on), OvidSP.</p> </li> </ul> <ul id="CD007988-list-0020"> <li> <p>CINAHL (Cumulative Index to Nursing and Allied Health Literature) (1980 to 2012) , EBSCOhost. </p> </li> </ul> <ul id="CD007988-list-0021"> <li> <p>PsycINFO (1806 on), OvidSP.</p> </li> </ul> </p> <p>Search strategies were comprised of keywords, when available, and controlled vocabulary such as MeSH (Medical Subject Headings). Two methodological search filters were used to limit retrieval to appropriate study designs: the Cochrane highly sensitive search strategy (sensitivity‐ and precision‐maximizing version, 2008 revision) (<a href="./references#CD007988-bbs2-0185" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) to identify RCTs, and an EPOC methodology filter to identify non‐RCT designs. Language restrictions were not applied. </p> </section> <section id="CD007988-sec-0040"> <h4 class="title">Searching other resources</h4> <p>We conducted handsearches of selected journals from 2000 to 2012. We also performed handsearching of reference lists of retrieved papers and relevant narrative or systematic reviews. To identify new and ongoing trials, we searched <a href="http://www.clinicaltrials.org" target="_blank">www.clinicaltrials.org</a> and <a href="http://www.controlled-trials.com/mrct" target="_blank">www.controlled‐trials.com/mrct</a>. </p> </section> </section> <section id="CD007988-sec-0041"> <h3 class="title" id="CD007988-sec-0041">Data collection and analysis</h3> <section id="CD007988-sec-0042"> <h4 class="title">Selection of studies</h4> <p>We used a three‐step study screening procedure. First, based on titles only, one review author (CA, GG or IPB) excluded obviously non‐pertinent references. These excluded references were double‐checked by a second review author (CA, GG or IPB) to approve the exclusions. Then, based on abstracts, two review authors (CA, GG, POB or IPB) independently, and in duplicate, excluded previously retained articles if they represented a non‐original study, were obviously not focused on asthma, were obviously not on chronic disease management, or were clearly on another topic. Finally, articles deemed potentially relevant by any review author had their full texts assessed for eligibility by two review authors (CA, GG, POB or IPB). Reasons for excluding studies based on the full‐text assessment are described in the Characteristics of excluded studies table. Any disagreement about eligibility was resolved by discussion between the review authors and with the involvement of an arbitrator as necessary. Multiple published articles from a single study were treated as a single intervention evaluation. Because chronic disease management programmes were developed and first described in the early 1990s, studies from 1990 onwards were selected. In addition, since we were interested in the effectiveness of chronic disease management in adult asthmatic patients (16 years and over), we selected studies involving adults. The latter limit did not, however, exclude studies including both adult and non‐adult patients (&lt; 16 years of age). </p> </section> <section id="CD007988-sec-0043"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (CA, GG or IPB) independently, and in duplicate, extracted data from selected studies using a tailored extraction form based on the generic Cochrane EPOC Review Group data collection checklist (<a href="./references#CD007988-bbs2-0172" title="EffectivePractice , Organisation of Care(EPOC) . Data extraction and management. EPOC Resources for review authors. Oslo:Norwegian Knowledge Centre for the Health Services 2013. Available at: http://epocoslo.cochrane.org/epoc‐specific‐resources‐review‐authors. ">EPOC 2013a</a>). Any disagreement was resolved by discussion and if disagreement persisted an arbitrator was involved, as necessary. Where required, we sought additional information by contacting corresponding authors.  </p> <p>Asthma severity was determined by study self‐report, examination of FEV1 and PEF, or chronicity of asthma symptoms at baseline. Patients were categorised as having severe asthma if they had a mean FEV1 or PEF less than 0.6 of the predicted value, or if they reported daily asthma symptoms (<a href="./references#CD007988-bbs2-0155" title="BatemanED , HurdSS , BarnesPJ , BousquetJ , DrazenJM , FitzGeraldM , et al. Global strategy for asthma management and prevention: GINA executive summary. The European Respiratory Journal2008;31(1):143‐78. ">Bateman 2008</a>). Whenever possible, we categorised study populations as 'moderate to severe' if asthmatics with severe asthma were enrolled in the study population, and 'mild to moderate' otherwise. </p> </section> <section id="CD007988-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (CA, GG or IPB) independently assessed the methodological quality of the included studies using the suggested risk of bias criteria for EPOC reviews (<a href="./references#CD007988-bbs2-0173" title="EffectivePractice , Organisation of Care(EPOC) . Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors. OsloNorwegian Knowledge Centre for the Health Services 2013. Available at: epocoslo.cochrane.org/epoc‐specific‐resources‐review‐authors. ">EPOC 2013b</a>). Each individual component (sequence generation, allocation concealment, blinding of outcome assessment, completeness of outcome data, selective outcome reporting, baseline characteristics, baseline outcomes measurements, protection against contamination, and other sources of bias) was explicitly rated and categorised as being at low, unclear, or high risk of bias. Any disagreement was resolved by discussion or involvement of an arbitrator, or both. If necessary, we contacted study authors for additional information or clarification of the study methods. The same risk of bias table was used for all study designs considered in the review. </p> <p>For sensitivity analyses, a summary assessment of the risk of bias of each study was done using one key domain of a study level entry (allocation concealment) and one key domain of an outcome level entry (incomplete outcome data) of the core Cochrane Collaboration tool. Studies were considered to be at: low risk of bias (high quality) if the two key domains were at low risk; at unclear risk of bias (moderate quality) if at least one of the key domains was at unclear risk and none at high risk; at high risk of bias (low quality) if at least one of the key domains was at high risk of bias. </p> </section> <section id="CD007988-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <p>In trials reporting score outcomes, we considered the results of the overall score if available. When not available, we selected one score or dimension of the scale as the representative outcome or calculated the average score if possible. If authors reported outcomes at more than one follow‐up period, we selected the period of follow‐up that matched the end of the intervention. The direction of the effect size was standardised so that a positive difference indicated improvement in the intervention group. Results of count data (that is, hospitalisations and ED or unscheduled visits) were treated as rate ratios. </p> <p>For RCTs and NRCTs, we reported results of dichotomous outcomes as odd ratios (OR) and results of continuous outcomes as mean differences (MD) or standardised mean differences (SMD) if outcomes related to scores, using post‐intervention (follow‐up) values. We used the latter because there were more studies reporting these values and corresponding standard deviations (SD) compared to change from baseline values. In addition, because the number of patients at baseline and follow‐up were often not the same, change scores for individual studies could not be calculated by hand. Sensitivity analyses, using change from baseline values and change from baseline SDs, were conducted to assess the robustness of results according to the choice of MD estimates if data permitted. </p> <p>Standardised effect sizes, which were calculated for continuous measures by dividing the difference in mean scores between the intervention and comparison group in each study by an estimate of the (pooled) SD, result in a 'scale free' estimate of the effect for each study. This can then be interpreted and pooled across studies regardless of the original scale of measurement used in each study (<a href="./references#CD007988-bbs2-0195" title="LairdNM , MostellerF . Some statistical methods for combining experimental results. International Journal of Technology Assessment in Health Care1990;6(1):5‐30. ">Laird 1990</a>). We re‐expressed SMDs using rules of thumb (SMD &lt; 0.4 = small effect, 0.4 to 0.7 = moderate effect , &gt; 0.7 = large effect) or using the most commonly used instrument (back‐transformation of the effect size) to have measures that are clinically useful in daily practice, following the method described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007988-bbs2-0185" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If available, we related the results to the minimal clinically important difference (MCID) of the instrument considered. </p> <p>For CBA studies, we planned to report results of dichotomous outcomes as risk ratio (RR) derived from statistical analyses adjusting for baseline measures (such as logistic regressions) and results of continuous outcomes as MD or SMD derived from statistical analyses adjusting for baseline measures (such as linear regression models, mixed models, or hierarchical models). If adjusted results were not available, study data were excluded from the analyses. </p> </section> <section id="CD007988-sec-0046"> <h4 class="title">Unit of analysis issues</h4> <section id="CD007988-sec-0047"> <h5 class="title">Cluster‐randomised trials</h5> <p>Some cluster‐randomised trials might have a unit of analysis error, when the trial has not adjusted for data clustering. This error implies that confidence intervals and standard errors of effects are smaller (more precise) than they should be (<a href="./references#CD007988-bbs2-0230" title="UkoumunneOC , GullifordMC , ChinnS , SterneJA , BurneyPG . Methods for evaluating area‐wide and organisation‐based interventions in health and health care: a systematic review. Health Technology Assessment1999;3(5):iii‐92. ">Ukoumunne 1999</a>). We noted the method of randomisation and unit of analysis for each included cluster trial and corrected the sample size by dividing it by the design effect, according to the guidance in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007988-bbs2-0185" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If the intraclass correlation coefficient or the number of clusters was not reported and attempts to contact the authors were unsuccessful, study data were excluded from the analyses. </p> </section> <section id="CD007988-sec-0048"> <h5 class="title">Cross‐over trials</h5> <p>In cross‐over trials, only data before cross‐over were considered to avoid any unit of analysis issues. </p> </section> <section id="CD007988-sec-0049"> <h5 class="title">Studies with multiple treatment groups</h5> <p>In studies with one control group and two or more intervention groups that satisfied our CDM criteria, we combined the intervention groups to create a single pair‐wise comparison to avoid unit of analysis errors. For dichotomous outcomes, both the sample size and the number of patients with events were summed across groups. For continuous outcomes, means and SDs were combined using the formulae presented in table 7.7.a of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007988-bbs2-0185" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> </section> <section id="CD007988-sec-0050"> <h4 class="title">Dealing with missing data</h4> <p>We contacted corresponding authors to request missing information whenever the published information did not allow us to decide whether to include or exclude a study. We also contacted them to get missing data (for example, SDs) in order to appropriately describe the study results or perform a meta‐analysis, or both. </p> <p>In cases where SDs and change from baseline SDs were not reported by the authors, we computed them from reported standard errors, P values, or confidence intervals. If none of these values were reported, we imputed the SD (or change from baseline SD) by calculating the mean SD (or change from baseline SD) of the other studies included in the meta‐analysis using the same scale (following the guidance of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007988-bbs2-0185" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>)). The method of imputation for each relevant study is described in the forest plot footnotes. The potential impact of missing data was addressed in the sensitivity analysis. </p> </section> <section id="CD007988-sec-0051"> <h4 class="title">Assessment of heterogeneity</h4> <p>As suggested in <a href="./references#CD007988-bbs2-0217" title="PigottT , ShepperdS . Identifying, documenting, and examining heterogeneity in systematic reviews of complex interventions. Journal of Clinical Epidemiology2013;66(11):1244‐50. [PUBMED: 23953079] ">Pigott 2013</a>, we considered heterogeneity in terms of substantive features of complex interventions, methodological and procedural features of studies, as well as research characteristics and reporting context. These sources are included in what others categorise as clinical, methodological, and statistical heterogeneity (<a href="./references#CD007988-bbs2-0177" title="GagnierJJ , MoherD , BoonH , BeyeneJ , BombardierC . Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature. BMC Medical Research Methodology2012;12:111. [PUBMED: 22846171] ">Gagnier 2012</a>; <a href="./references#CD007988-bbs2-0178" title="GagnierJJ , MorgensternH , AltmanDG , BerlinJ , ChangS , McCullochP , et al. Consensus‐based recommendations for investigating clinical heterogeneity in systematic reviews. BMC Medical Research Methodology2013;13:106. [PUBMED: 24004523] ">Gagnier 2013</a>). Statistical heterogeneity among trials was specifically examined with Cochran's Q test and by calculating the I<sup>2</sup> statistic, which describe the proportion of variability in the summary estimate that is due to heterogeneity rather than by chance. </p> <p>We conducted subgroup analyses to explore clinical heterogeneity in meta‐analyses including at least nine studies, according to the following planned study characteristics (unless specified as post hoc). </p> <p> <ul id="CD007988-list-0022"> <li> <p>Comprehensiveness of the programme</p> </li> </ul> </p> <p>We defined a comprehensive programme as including at least the median number of independent components of included studies (that is, eight components). </p> <p> <ul id="CD007988-list-0023"> <li> <p>Dominant component of the programme</p> </li> </ul> </p> <p>Two review authors (CA, IPB) independently, and in duplicate, selected a dominant component of the programme out of the following three main categories, which are linked to the first three criteria of the operational definition of CDM: organisational component targeting patients, organisational component targeting healthcare professionals or system, or educational component. It was done based on the number of various components present in each category, the main aim of the intervention, and the relative importance of the different components. If we could not determine one dominant component, we classified the CDM programme as mixed. Any disagreement was resolved by discussion. </p> <p> <ul id="CD007988-list-0024"> <li> <p>Presence of limited CDM components in the control group (which were considered as usual care in the specific context of single studies) (post hoc) </p> </li> </ul> </p> <p>We did not perform meta‐regression because there were less than 10 studies in our meta‐analyses. </p> </section> <section id="CD007988-sec-0052"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed the presence of publication bias by means of funnel plots. This was done for exploratory purposes only, as the number of studies included in the meta‐analyses (less than 10) was insufficient to reach a conclusive result. </p> </section> <section id="CD007988-sec-0053"> <h4 class="title">Data synthesis</h4> <p>Where possible, we conducted meta‐analyses using the Cochrane Review Manager software (<a href="./references#CD007988-bbs2-0221" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>) to calculate the overall effect size for all relevant primary outcomes. We pooled results of the RCTs and NRCTs separately using the random‐effects model (<a href="./references#CD007988-bbs2-0164" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7:177‐88. ">DerSimonian 1986</a>) to incorporate some level of expected heterogeneity among pooled studies. All results were expressed with 95% confidence intervals. Baseline‐adjusted results for CBA studies were also combined separately, if available. For primary outcomes that could not be incorporated in a meta‐analysis, we provided a brief description of the results in the main text. </p> <p>We presented the most important outcomes of the review in the <a href="./full#CD007988-tbl-0001">summary of findings Table for the main comparison</a>, which includes an overall grading of the evidence using the GRADE approach, according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007988-bbs2-0185" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). This approach specifies four levels of quality (high, moderate, low, very low) for each outcome separately. The highest quality rating is for RCT evidence, but it can be downgraded depending on the presence of the following five factors: study limitations in the design and implementation suggesting high likelihood of bias; indirectness of evidence (indirect population, intervention, control, outcomes); unexplained heterogeneity or inconsistency of results (including problems with subgroup analyses); imprecision of results (wide confidence intervals); and high probability of publication bias. Sound observational studies are generally rated as low quality but the following factors can increase the quality of evidence: large magnitude of effect; all plausible confounding would reduce a demonstrated effect; and a dose‐response gradient. </p> </section> <section id="CD007988-sec-0054"> <h4 class="title">Sensitivity analysis</h4> <p>We explored the influence of the following characteristics on effect size: excluding studies at high risk of bias; excluding studies with imputed SDs; excluding studies using instruments of unknown validity; using change from baseline measures; and using the fixed‐effect model instead of random‐effects model. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007988-sec-0055" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007988-sec-0055"></div> <section id="CD007988-sec-0056"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD007988-sec-0110" title="">Characteristics of included studies</a>; <a href="./references#CD007988-sec-0111" title="">Characteristics of excluded studies</a>. </p> <section id="CD007988-sec-0057"> <h4 class="title">Results of the search</h4> <p>See: <a href="#CD007988-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD007988-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram." data-id="CD007988-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> </div> <p>We identified a total of 10,593 records to June 2014. We screened the full texts of 425 potentially relevant articles. Of these, we excluded 395 articles, classified 3 articles (corresponding to 2 studies) under ongoing studies and retained 20 studies (from 27 articles) that met all our inclusion criteria. </p> </section> <section id="CD007988-sec-0058"> <h4 class="title">Included studies</h4> <section id="CD007988-sec-0059"> <h5 class="title">Design and setting</h5> <p>An overview of the characteristics of the included studies is provided in <a href="#CD007988-tbl-0002">Table 1</a>. </p> <div class="table" id="CD007988-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of characteristics of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Design (allocation)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country and setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention name, duration, number of components, dominant component</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patients in intervention group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patients in control group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of reported outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCTs</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Armour 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C‐RCT</p> <p>(pharmacy)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> <p>rural and urban pharmacies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacy Asthma Care Program</p> <p>6 months</p> <p>components: 8</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 160</p> <p>women: 67.5%</p> <p>mean age: 47.5</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 186</p> <p>women: 60.5%</p> <p>mean age: 50.4</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org: 1</p> <p>Process: 6</p> <p>QOL: 1</p> <p>Symptoms/activity: 2</p> <p>Self‐care: 5</p> <p>Lung function: 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cambach 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Netherlands</p> <p>local physiotherapy</p> <p>practices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rehabilitation programme</p> <p>3 months</p> <p>components: 6</p> <p>dominant component: ORG_PT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 22</p> <p>women: 81.8%</p> <p>mean age: 40</p> <p>mild‐moderate asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 21</p> <p>women: 66.7%</p> <p>mean age: 53</p> <p>mild‐moderate asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>QOL: 1</p> <p>Symptoms/activity: 3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Castro 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>inpatients and outpatients</p> <p>in a hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Use of an asthma nurse specialist to provide a multifaceted approach to</p> <p>asthma care for “high‐risk” inpatients</p> <p>6 months</p> <p>components: 10</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 50</p> <p>women: 80%</p> <p>mean age: 35</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 46</p> <p>women: 85%</p> <p>mean age: 38</p> <p>mod‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 8</p> <p>QOL: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Charrois 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada</p> <p>community rural pharmacies and PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Better Respiratory Education and Asthma Treatment in Hinton and Edson (BREATHE)</p> <p>6 months</p> <p>components: 11</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 36</p> <p>women: 53%</p> <p>mean age: 35.7</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 34</p> <p>women: 53%</p> <p>mean age: 38.7</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org: 1</p> <p>Process: 3</p> <p>HC use: 1</p> <p>Symptoms/activity: 2</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Couturaud 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>France</p> <p>outpatient clinic of two university hospitals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Educational programme in asthmatic patients following treatment readjustment</p> <p>12 months</p> <p>components: 7</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 26</p> <p>women: 69.4%</p> <p>mean age: 37.8</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 28</p> <p>women: 66.7%</p> <p>mean age: 38.1</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 1</p> <p>QOL:1</p> <p>Symptoms/activity: 3</p> <p>Self‐care: 3</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Galbreath 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>University Medical Center</p> <p>and PCP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The South Texas Asthma Management Project (STAMP)</p> <p>6 months</p> <p>components: 9</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 262</p> <p>women: 77.6%</p> <p>mean age: 42.3</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 124</p> <p>women: 77.6%</p> <p>mean age: 43.7</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org: 1</p> <p>Process: 2</p> <p>HC use: 4</p> <p>QOL: 1</p> <p>Symptoms/activity: 2</p> <p>Lung function: 3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Huang 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan</p> <p>outpatient chest department</p> <p>of hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individualised self‐care education programme</p> <p>6 months</p> <p>components: 6</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 98</p> <p>women: 29.5%</p> <p>mean age: na</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 50</p> <p>women: 22%</p> <p>mean age: na</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 1</p> <p>HC use: 1</p> <p>Symptoms/activity: 2</p> <p>Self‐care: 3</p> <p>Lung function: 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kokubu 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Japan</p> <p>hospital and patients' home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma telemedicine system</p> <p>6 months</p> <p>components: 8</p> <p>dominant component: ORG_HC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 32</p> <p>women: 62%</p> <p>mean age: 49.9</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 34</p> <p>women: 56%</p> <p>mean age: 47.3</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 4</p> <p>Pt satis: 1</p> <p>QOL: 1</p> <p>Symptoms/activity: 3</p> <p>Self‐care: 3</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Martin 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A community‐based intervention to improve asthma self‐efficacy in African</p> <p>American adults designed by the Chicago Initiative to Raise Asthma</p> <p>Health Equity (CHIRAH)</p> <p>3 months</p> <p>components: 7</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 19</p> <p>women: 60%</p> <p>mean age: 33</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 18</p> <p>women: 77%</p> <p>mean age: 37</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org: 1</p> <p>Process: 2</p> <p>QOL: 1</p> <p>Symptoms/activity: 3</p> <p>Self‐care: 3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mayo 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>outpatient chest clinic of a hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outpatient programme designed to reduce readmissions for asthma exacerbations</p> <p>8 months</p> <p>components: 6</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 47</p> <p>women: 70.2%</p> <p>mean age: 42</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 57</p> <p>women: 57.9%</p> <p>mean age: 42</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 1</p> <p>Symptoms/activity: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McLean 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada</p> <p>community pharmacies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The British Columbia pharmacy asthma study incorporating an asthma care</p> <p>protocol provided by specially trained community pharmacists</p> <p>12 months</p> <p>components: 7</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 119</p> <p>women: 63%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 105</p> <p>women: 62.9%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 4</p> <p>Pt satis: 1</p> <p>QOL: 1</p> <p>Symptoms/activity: 4</p> <p>Self‐care: 1</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Petro 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C‐RCT</p> <p>(provider)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Germany PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A disease management programme with a case manager</p> <p>12 months</p> <p>components: 7</p> <p>dominant component: ORG_HC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 56</p> <p>women: 54.2%</p> <p>mean age: 57.3</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 55</p> <p>women: 44%</p> <p>mean age: 55</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 2</p> <p>QOL: 3</p> <p>Symptoms/activity: 1</p> <p>Lung function: 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Schatz 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>Kaiser Permanente Medical Care program</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Regular care manager and intensive individualised educational visit</p> <p>12 months</p> <p>components: 11</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 30</p> <p>women: 32.3%</p> <p>mean age: 45</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 15</p> <p>women: 54.8%</p> <p>mean age: 45.4</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 1</p> <p>HC use: 1</p> <p>QOL: 1</p> <p>Symptoms/activity: 2</p> <p>Self‐care: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Smith 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> <p>outpatient asthma clinics of</p> <p>a hospital and PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The Coping with Asthma Study (a home based, nurse led psychoeducational</p> <p>intervention for adults at risk of adverse asthma outcomes)</p> <p>6 months</p> <p>components: 15</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 42</p> <p>women: 62%</p> <p>mean age: 38.2</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 42</p> <p>women: 84%</p> <p>mean age: 34.7</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>QOL: 6</p> <p>Symptoms/activity: 1</p> <p>Self‐care: 6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wilson 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>Kaiser Permanente clinics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The Better Outcomes of Asthma Treatment (BOAT) study</p> <p>9 months</p> <p>components: 9</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 362</p> <p>women: 56.2%</p> <p>mean age: 46.3</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 189</p> <p>women: 57.4%</p> <p>mean age: 45.1</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 1</p> <p>HC use: 2</p> <p>QOL: 1</p> <p>Symptoms/activity: 5</p> <p>Lung function: 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NRCT</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Herborg 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C‐NRCT</p> <p>(pharmacy)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> <p>community pharmacies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapeutic outcomes monitoring (TOM) programme</p> <p>12 months</p> <p>components: 9</p> <p>dominant component: ORG_PT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 209</p> <p>women: 57.6%</p> <p>mean age: 38.8</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 204</p> <p>women: 54.7%</p> <p>mean age: 42.4</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org : 3</p> <p>HC use: 7</p> <p>Pt satis: 1</p> <p>QOL: 2</p> <p>Symptoms/activity: 4</p> <p>Self‐care: 1</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CBAs</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Feifer 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>PCPs in a region covered by a health insurance company</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Population‐based asthma disease management programme using broad‐based</p> <p>educational interventions</p> <p>12 months</p> <p>components: 7</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 35,450</p> <p>women: 56%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 35,450</p> <p>women: 56%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 3</p> <p>HC use: 3</p> <p>QOL: 1</p> <p>Symptoms/activity: 4</p> <p>Self‐care: 3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Landon 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>community health centres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health Disparities Collaboratives disseminating quality improvement techniques</p> <p>54 months</p> <p>components: ≥ 11</p> <p>dominant component: ORG_HC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 1696 (total/2)</p> <p>women: 63.5%</p> <p>mean age: 28.4</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 1696 (total/2)</p> <p>women: 67.6%</p> <p>mean age: 34.4</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 7</p> <p>HC use: 1</p> <p>Symptoms/activity: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Weng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan</p> <p>outpatient clinics of a</p> <p>hospital and PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A government‐sponsored outpatient‐based disease management programme</p> <p>12 months</p> <p>components: 8</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 854</p> <p>women: 44.5%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 3188</p> <p>women: 43%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pro satis: 1</p> <p>HC use: 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Windt 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Germany</p> <p>PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nationwide asthma disease management programme</p> <p>&gt; 12 months</p> <p>components: ≥ 5</p> <p>dominant component: ORG_HC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N=317</p> <p>women: 48.6%</p> <p>mean age: 36.5</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N=317</p> <p>women: 44.2%</p> <p>mean age: 36.5</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 8</p> <p>HC use: 2</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>RCT: randomised controlled trial, NRCT: non‐randomised controlled trial, CBA: controlled before‐after study, C‐: cluster, PCP: primary care practice, EDU: educational and self‐management support component, ORG_PAT: organisational component targeting patients; ORG_HC organisational component targeting healthcare professionals or the healthcare system, na: not available, HC: healthcare, QOL: quality of life, Org: organisational, Pt satis: patient satisfaction, Pro satis: healthcare professionals' satisfaction </p> </div> </div> <p>Fifteen studies were RCTs. Out of these 15 studies, one study was a cross‐over trial (<a href="./references#CD007988-bbs2-0002" title="CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC . The effects of a community‐based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. European Respiratory Journal1997;10(1):104‐13. CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC , RijswijkH . Feasibility of a pulmonary rehabilitation programme in community based physiotherapy practices. Journal of Rehabilitation Sciences1994;7(4):104‐12. ">Cambach 1997</a>) and two studies were cluster‐RCTs with the unit of allocation being the provider in <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a> and the pharmacy in <a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>. The other studies included were one NRCT (<a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>) with a cluster design (unit of allocation: pharmacy) and four CBAs (<a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>; <a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>; <a href="./references#CD007988-bbs2-0018" title="WengHC . Impacts of a government‐sponsored outpatient‐based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Disease Management2005;8(1):48‐58. ">Weng 2005</a>; <a href="./references#CD007988-bbs2-0020" title="WindtR , GlaeskeG . Effects of a German asthma disease management program using sickness fund claims data. Journal of Asthma2010;47(6):674‐9. ">Windt 2010</a>) with at least two sites in both the control and intervention groups. </p> <p>Nine studies recruited patients from primary care clinics or pharmacies (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>; <a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>). Two studies enrolled patients from respiratory care clinics (<a href="./references#CD007988-bbs2-0002" title="CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC . The effects of a community‐based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. European Respiratory Journal1997;10(1):104‐13. CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC , RijswijkH . Feasibility of a pulmonary rehabilitation programme in community based physiotherapy practices. Journal of Rehabilitation Sciences1994;7(4):104‐12. ">Cambach 1997</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>), three other studies recruited hospital inpatients (<a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>; <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>), and four studies enrolled patients from the general population (<a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>; <a href="./references#CD007988-bbs2-0018" title="WengHC . Impacts of a government‐sponsored outpatient‐based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Disease Management2005;8(1):48‐58. ">Weng 2005</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>; <a href="./references#CD007988-bbs2-0020" title="WindtR , GlaeskeG . Effects of a German asthma disease management program using sickness fund claims data. Journal of Asthma2010;47(6):674‐9. ">Windt 2010</a>). The remaining two studies enrolled patients from more than one pool: <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a> enrolled patients from both primary care and respiratory care clinics; and <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a> recruited patients from the general population, primary care clinics and respiratory care clinics. </p> <p>Three studies took place in pharmacies (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>), seven in primary care practices (<a href="./references#CD007988-bbs2-0002" title="CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC . The effects of a community‐based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. European Respiratory Journal1997;10(1):104‐13. CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC , RijswijkH . Feasibility of a pulmonary rehabilitation programme in community based physiotherapy practices. Journal of Rehabilitation Sciences1994;7(4):104‐12. ">Cambach 1997</a>; <a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>; <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>; <a href="./references#CD007988-bbs2-0020" title="WindtR , GlaeskeG . Effects of a German asthma disease management program using sickness fund claims data. Journal of Asthma2010;47(6):674‐9. ">Windt 2010</a>), three in outpatient hospital departments (<a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>), and two in health management organisations (HMOs) (<a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>). The remaining studies took place in mixed settings: inpatient and outpatient hospital departments (<a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>), inpatient hospital department and patients' home (<a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>), pharmacies and primary care practices (<a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>), and outpatient hospital departments and primary care clinics (<a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>; <a href="./references#CD007988-bbs2-0018" title="WengHC . Impacts of a government‐sponsored outpatient‐based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Disease Management2005;8(1):48‐58. ">Weng 2005</a>). </p> <p>Ten studies were carried out in North America, six in Europe, three in Asia, and one in Australia. </p> </section> <section id="CD007988-sec-0060"> <h5 class="title">Study population</h5> <p>A total of 10,846 patients were included in 19 studies (between 37 and 4042 patients per study, median 111) when the CBA study reporting data from 70,900 patients from a health insurance company database was excluded (<a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>). The mean age in the intervention and control groups varied between 28.0 and 57.3 years old (median 42.0) and the percentage of women between 22% and 85% (median 59%). Asthma severity in the 13 studies reporting it was rated as moderate‐severe in all except one study, where it was mild‐moderate (<a href="./references#CD007988-bbs2-0002" title="CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC . The effects of a community‐based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. European Respiratory Journal1997;10(1):104‐13. CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC , RijswijkH . Feasibility of a pulmonary rehabilitation programme in community based physiotherapy practices. Journal of Rehabilitation Sciences1994;7(4):104‐12. ">Cambach 1997</a>). The baseline predicted FEV1 varied between 22.5% and 89% (median 69%) in eight studies where it was reported. The percentage of patients using inhaled corticosteroids was reported to be between 13.3% and 100% (median 78%) in six studies. </p> </section> <section id="CD007988-sec-0061"> <h5 class="title">Interventions</h5> <p>See: <a href="#CD007988-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD007988-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Description of intervention components by study." data-id="CD007988-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Description of intervention components by study.</p> </div> </div> </div> <p>All the programmes met the predefined five CDM criteria: at least one organisational component targeting patients, at least one organisational component targeting healthcare professionals or the healthcare system, patient education or self‐management support or both, the active involvement of two or more healthcare professionals in patient care, and a minimum duration of three months for at least one component. The number of independent components per programme ranged from 6 to 15 (mean 8.4; median 8). Eleven programmes comprising eight or more components (that is, including at least the median number of components) were defined as comprehensive programmes (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>; <a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>; <a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>; <a href="./references#CD007988-bbs2-0018" title="WengHC . Impacts of a government‐sponsored outpatient‐based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Disease Management2005;8(1):48‐58. ">Weng 2005</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>), and the remaining nine, comprising seven or fewer components, were defined as less comprehensive. </p> <p>The dominant component was 'educational' in eight studies, 'organisational targeting healthcare professionals or the healthcare system' in four studies, and 'organisational targeting patients' in two studies. We could not determine the dominant component in the remaining six studies, which were classified as mixed. </p> <p>The most frequently assessed educational component was individual educational sessions (n = 19), followed by providing an action plan for self‐management support (n = 12), and verification of inhalation technique (n = 9). The most frequently assessed organisational component targeting patients involved structured follow‐up (n = 16), followed by having assistance and advice on demand via, for example, a hotline (n = 6). The most frequently assessed organisational component targeting healthcare professionals or the healthcare system involved explicit teamwork and collaborative processes between the healthcare providers (n = 15), followed by education and training of providers (n = 10), and explicit use of evidence‐based medicine supports (n = 9). </p> <p>The duration of the programmes ranged from 3 months to more than 12 months (median 8.5 months). </p> <p>Three studies assessed two intervention groups that fulfilled our CDM inclusion criteria (<a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>). In these studies, we combined the two intervention arms and analysed them as a single intervention group. </p> </section> <section id="CD007988-sec-0062"> <h5 class="title">Outcome (dependent variable) measures</h5> <p>A wide variety of outcomes were reported in the included studies (see <a href="./references#CD007988-sec-0110" title="">Characteristics of included studies</a> for all available outcomes). Here we describe briefly the outcomes reported in at least three studies. The a priori primary outcomes we defined in the protocol are the only ones we analysed. They are described in more detail in the section presenting the effects of the interventions. </p> <p>Five studies reported patient participation rates in the programme and four reported the percentage of patients who received the intervention or components, or both. Five studies reported the percentage of patients with an action plan. Six studies reported prescription rates of inhaled corticosteroids and nine reported rates for prescription of other types of medication. </p> <p>Fifteen studies reported healthcare utilisation outcomes: four reported on any healthcare use (hospitalisation or unscheduled visit, or both), and seven reported asthma‐related or all‐cause hospitalisations and asthma‐related or all‐cause unscheduled visits separately. Five studies reported cost data. </p> <p>Fourteen studies reported asthma‐specific quality of life scores. Asthma severity scores were reported in nine studies and the number of symptomatic days in four studies. Three studies reported the number of days off work or school due to asthma. Ten studies reported the patients' actual use of medication. The reported self‐management outcomes included patients' asthma knowledge scores in seven studies, self‐efficacy scores in six studies, and compliance with treatment in four studies. </p> <p>Pulmonary function tests such as FEV1, FEV1/FVC and PEF rate were reported in seven, four, and six studies, respectively. </p> </section> <section id="CD007988-sec-0063"> <h5 class="title">Missing data</h5> <p>We attempted to contact the authors of 15 of the included studies to request additional data or information. We sent e‐mails to 10 authors as we were unable to identify the correct e‐mail address for the authors of the other five studies. Nine authors responded and five provided additional data. We imputed missing SDs for seven studies (<a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>; <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>). </p> </section> </section> <section id="CD007988-sec-0064"> <h4 class="title">Excluded studies</h4> <p>We excluded 395 studies after having assessed the full article (see <a href="#CD007988-fig-0001">Figure 1</a>). We excluded 211 studies because the intervention did not meet the inclusion criteria of our CDM operational definition. We also excluded studies that used a design not included in our predefined list, for example a before‐after study with only one site for the intervention and control groups, even if they met or possibly met the inclusion criteria for our operational definition of CDM (n = 66). We also excluded studies for the following reasons: inappropriate target population (for example, only children included; n = 13); insufficient information to determine eligibility (n = 25); publication date before 1990, as the first CDM programmes were implemented after that date (n = 4); not primary studies (for example, editorials, comments, reviews; n = 58); and patients without asthma or from a mix of chronic diseases (n = 9). One study fulfilled our eligibility criteria but did not report appropriate outcomes. The primary reason for excluding studies that seemed to meet the eligibility criteria and could be considered relevant by some readers, but were not eligible after further inspection, are listed under <a href="./references#CD007988-sec-0111" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD007988-sec-0065"> <h3 class="title">Risk of bias in included studies</h3> <p>The full details of risk of bias judgements by study are described in the <a href="./references#CD007988-sec-0110" title="">Characteristics of included studies</a> table. <a href="#CD007988-fig-0003">Figure 3</a> and <a href="#CD007988-fig-0004">Figure 4</a> summarise these. Using GRADE (see <a href="./full#CD007988-tbl-0001">summary of findings Table for the main comparison</a>) the quality of the evidence was rated as moderate or low depending on the outcome. </p> <div class="figure" id="CD007988-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007988-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD007988-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007988-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD007988-sec-0066"> <h4 class="title">Allocation</h4> <p>Ten of the 15 RCTs reported the use of a computerised randomisation programme or a random number table to generate the allocation sequence and were thus considered to be at low risk of bias (<a href="./references#CD007988-bbs2-0002" title="CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC . The effects of a community‐based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. European Respiratory Journal1997;10(1):104‐13. CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC , RijswijkH . Feasibility of a pulmonary rehabilitation programme in community based physiotherapy practices. Journal of Rehabilitation Sciences1994;7(4):104‐12. ">Cambach 1997</a>; <a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>; <a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>). The process of sequence generation was unclear for four studies, which stated that the study groups were randomly allocated (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>). The remaining RCT was judged to have a high risk of bias because a quasi‐random method of allocation (last digit of hospital number) was used (<a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>). In the NRCT and CBAs, allocation was judged to be at high risk of bias because of absence of randomisation (<a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>; <a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>) and retrospective allocation (<a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>; <a href="./references#CD007988-bbs2-0018" title="WengHC . Impacts of a government‐sponsored outpatient‐based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Disease Management2005;8(1):48‐58. ">Weng 2005</a>; <a href="./references#CD007988-bbs2-0020" title="WindtR , GlaeskeG . Effects of a German asthma disease management program using sickness fund claims data. Journal of Asthma2010;47(6):674‐9. ">Windt 2010</a>). </p> <p>Allocation concealment was reported in nine of the randomised studies but was unclear in the other six (<a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>; <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>; <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>). Allocation was judged as not having been done in the other studies included (NRCT and CBAs). </p> <section id="CD007988-sec-0067"> <h5 class="title">Unit of allocation issues</h5> <p>Two of the three studies with a cluster design analysed the data taking into account the clustering effect (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>) and were included in our analyses. The third study (<a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>) analysed the data at the patient level, which artificially increases the precision of the statistical tests and can lead to inappropriate conclusions. The results of this study were excluded from all analyses because we were unable to determine the number of clusters in the study and therefore could not adjust the results. </p> </section> </section> <section id="CD007988-sec-0068"> <h4 class="title">Blinding</h4> <p>Six studies were at low risk of performance and detection bias because claims data were used or the assessors were blinded (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>; <a href="./references#CD007988-bbs2-0020" title="WindtR , GlaeskeG . Effects of a German asthma disease management program using sickness fund claims data. Journal of Asthma2010;47(6):674‐9. ">Windt 2010</a>). Two studies were judged to be at high risk (<a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>) and the risk for the remaining 12 studies was unclear. </p> </section> <section id="CD007988-sec-0069"> <h4 class="title">Incomplete outcome data</h4> <p>Outcome data were considered complete when 80% or more of randomised patients were included in the analyses, when reasons for attrition were similar across groups, and when dropouts did not differ from the patients analysed. These were reported in nine studies (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0002" title="CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC . The effects of a community‐based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. European Respiratory Journal1997;10(1):104‐13. CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC , RijswijkH . Feasibility of a pulmonary rehabilitation programme in community based physiotherapy practices. Journal of Rehabilitation Sciences1994;7(4):104‐12. ">Cambach 1997</a>; <a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>; <a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>; <a href="./references#CD007988-bbs2-0020" title="WindtR , GlaeskeG . Effects of a German asthma disease management program using sickness fund claims data. Journal of Asthma2010;47(6):674‐9. ">Windt 2010</a>). Outcome data were considered incomplete in three studies because less than 80% of randomised patients were analysed and no reasons were given for the missing data (<a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>). In the remaining eight studies, the number of patients or clusters lost to follow‐up was unclear or information was missing for us to fully assessed attrition bias (<a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>; <a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>; <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>; <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>; <a href="./references#CD007988-bbs2-0018" title="WengHC . Impacts of a government‐sponsored outpatient‐based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Disease Management2005;8(1):48‐58. ">Weng 2005</a>). </p> </section> <section id="CD007988-sec-0070"> <h4 class="title">Selective reporting</h4> <p>Only one study published an article on the design of the trial, reporting the outcomes to be measured in the trial (<a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>), and was considered at low risk of reporting bias. All other studies were categorised as having an unclear risk of reporting bias because of missing information. </p> <p>None of the exploratory funnel plots appeared asymmetrical.</p> </section> <section id="CD007988-sec-0071"> <h4 class="title">Other potential sources of bias</h4> <p>Baseline measurement of the outcome of interest was reported in all studies except three (<a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>). In 10 of the studies reporting baseline measures, study groups were comparable at baseline for the outcomes (<a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>; <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>; <a href="./references#CD007988-bbs2-0018" title="WengHC . Impacts of a government‐sponsored outpatient‐based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Disease Management2005;8(1):48‐58. ">Weng 2005</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>; <a href="./references#CD007988-bbs2-0020" title="WindtR , GlaeskeG . Effects of a German asthma disease management program using sickness fund claims data. Journal of Asthma2010;47(6):674‐9. ">Windt 2010</a>); while in one study important differences were reported (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>), it was unclear if the differences in baseline measurements of the outcomes between groups were important in five studies. Finally, in one study (<a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>) there were important differences at baseline for the secondary outcomes but not the primary outcome (marked as unclear risk of bias). </p> <p>All studies except two (<a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>) reported patients' characteristics at baseline allowing an assessment of baseline heterogeneity between study groups. Four studies reported important differences between groups (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0002" title="CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC . The effects of a community‐based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. European Respiratory Journal1997;10(1):104‐13. CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC , RijswijkH . Feasibility of a pulmonary rehabilitation programme in community based physiotherapy practices. Journal of Rehabilitation Sciences1994;7(4):104‐12. ">Cambach 1997</a>; <a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>) (at high risk of bias), 13 studies reported no important differences (at low risk of bias), and one study (<a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>) reported important differences for some characteristics (at unclear risk). </p> <p>Two studies (<a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>) were considered at high risk of contamination: trained pharmacists saw both the control and intervention patients. In five studies (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>; <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>) it was unclear whether patients in the control groups had received more than usual care, which could have improved the care they had received and their outcomes. The other 13 studies were considered at low risk of contamination. </p> <p>While no further bias was detected in 13 studies, five studies were considered at high risk and two at unclear risk for other bias. In four studies (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>) there was a risk of recruitment bias due to the design of the study (for example, selection of patients by pharmacist after allocation, low recruitment rate). In two other studies (<a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>) the intervention was poorly implemented with patients allocated to the intervention group completing only parts of the intervention, resulting in potential bias. Finally, in two studies (<a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>) there was a high risk of bias due to analysis errors (unit of analysis error, cluster randomisation but analyses performed with patient level data). </p> </section> </section> <section id="CD007988-sec-0072"> <h3 class="title" id="CD007988-sec-0072">Effects of interventions</h3> <p>See: <a href="./full#CD007988-tbl-0001"><b>Summary of findings for the main comparison</b> Chronic disease management compared with usual care for adults with asthma</a> </p> <p>We reported the results using the 10 primary outcomes as predefined in our protocol, followed by the results of subgroup and additional sensitivity analyses. Data from one RCT (<a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>) could not be included in the meta‐analyses because we were unable to calculate the design effect due to missing information on the number of clusters (unit of analysis error). Also, we were unable to include the four CBA studies in the meta‐analyses in this report because data provided by authors were either insufficient or unadjusted. </p> <section id="CD007988-sec-0073"> <h4 class="title">Asthma‐specific quality of life</h4> <p>Fourteen of the 20 studies selected for inclusion in this review measured asthma‐specific quality of life using three validated instruments: the Asthma Quality of Life Questionnaire (AQLQ) or mini‐AQLQ in nine studies; the Living with Asthma Questionnaire (LWAQ) in four studies; and the Chronic Respiratory Disease Questionnaire (CRDQ) in one study. However, only nine of these studies provided data at follow‐up and could be included in the main meta‐analysis. Of these, two had missing SDs, which were estimated from the study data using the same instrument. </p> <p>One study using the mini‐AQLQ was excluded from the meta‐analysis because follow‐up values were not available, due to copyright issues according to the corresponding author (<a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>). In this study, the intervention group had improved asthma quality of life compared with the control group after six months of follow‐up. Another study using the LWAQ (<a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>) was excluded from the meta‐analysis as data could not be adjusted for unit of analysis error. The study using the CRDQ (<a href="./references#CD007988-bbs2-0002" title="CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC . The effects of a community‐based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. European Respiratory Journal1997;10(1):104‐13. CambachW , Chadwick‐StraverRV , WagenaarRC , vanKeimpemaAR , KemperHC , RijswijkH . Feasibility of a pulmonary rehabilitation programme in community based physiotherapy practices. Journal of Rehabilitation Sciences1994;7(4):104‐12. ">Cambach 1997</a>) and one study using the LWAQ (<a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>) only provided data on change from baseline. They were excluded from the main meta‐analysis but we included them in the sensitivity analysis using change from baseline data. <a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>, using the mini‐AQLQ, was excluded from the meta‐analysis because it was a CBA study and data were available only for the intervention group. </p> <p>The main meta‐analysis included eight RCTs (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>) with a total population of 1627 patients with a follow‐up of 3 to 12 months (see <a href="#CD007988-fig-0005">Figure 5</a>; <a href="./references#CD007988-fig-0008" title="">Analysis 1.1</a>). The pooled SMD was 0.22 in favour of CDM (95% confidence interval (CI) 0.08 to 0.37), with a moderate degree of heterogeneity (I<sup>2</sup> = 43%). The clinical significance of this SMD was low since, as a rule of thumb, a SMD lower than 0.4 indicates a small effect. In addition, the corresponding difference on the AQLQ scale after back‐transformation (0.30) was lower than the minimal clinically important difference (MCID) of the AQLQ or mini‐AQLQ, which is 0.5 according to the developers of the instrument (<a href="http://www.qoltech.co.uk/miniaqlq.html" target="_blank">http://www.qoltech.co.uk/miniaqlq.html</a>). The SMD for the NRCT (<a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>), including 413 patients, was larger than the pooled SMD of RCTs (SMD 0.46, 95% CI 0.27 to 0.66) (see <a href="#CD007988-fig-0005">Figure 5</a>; <a href="./references#CD007988-fig-0008" title="">Analysis 1.1</a>). </p> <div class="figure" id="CD007988-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.1 Asthma‐specific quality of life score (post‐intervention measurements)." data-id="CD007988-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.1 Asthma‐specific quality of life score (post‐intervention measurements). </p> </div> </div> </div> <p>Excluding the two RCTs at high risk of bias (<a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>) from the meta‐analysis reduced the SMD (SMD 0.17, 95% CI 0.05 to 0.28) and the heterogeneity (I<sup>2</sup> = 1%). </p> <section id="CD007988-sec-0074"> <h5 class="title">Subgroup analysis by quality of life instrument used</h5> <p>To determine if the heterogeneity of the results was due to the use of different instruments, we analysed the results from each instrument separately. This allowed us: i) to assess the effect of using a single instrument with its specific properties, and ii) to analyse the MD instead of the SMD. Seven studies including 1543 patients used the AQLQ, and one study including 84 patients used the LWAQ (<a href="./references#CD007988-fig-0012" title="">Analysis 1.5</a>). Subgroup analysis of the studies using the AQLQ scale showed a non‐clinically significant MD of 0.32 (clinical significance 0.5 or more) in favour of CDM (95% CI 0.12 to 0.52), while results of the study using the LWAQ scale were inconclusive (MD 0.02, 95% CI ‐0.16 to 0.20). Heterogeneity was not improved by restricting the analysis to studies using the same instrument (I<sup>2</sup> = 42%). </p> </section> </section> <section id="CD007988-sec-0075"> <h4 class="title">Hospitalisations</h4> <p>Nine studies reported hospitalisation data specifically. However, we could not perform a meta‐analysis because the data were skewed and heterogeneous, with wide variability in terms of length of measurement (hospitalisations within the last 1, 6, 8, or 12 months) and reasons for hospitalisation (due to asthma or any cause). </p> <p>Three RCTs reported a reduction in hospitalisation for asthma in the intervention group compared with the control group. While <a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a> reported a 56% reduction in readmissions for asthma in the intervention group compared with the control group over 12 months (MD ‐0.5, 95% CI ‐1.0 to 0.0), <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a> reported an 83% reduction in hospitalisations among patients at high risk for hospitalisations in the intervention group after 6 months compared with the control group (MD ‐0.29, 95% CI ‐0.49 to ‐0.09), and <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a> reported a 67% reduction in hospital readmissions for acute exacerbation in the intervention group after 8 months compared with the control group (MD ‐0.83, 95% CI ‐1.10 to ‐0.56). </p> <p>In contrast, two RCTs (<a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>) and one NRCT (<a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>) did not report any differences between groups. However, the number of hospitalisations per patient during follow‐up was lower in these studies than in the RCTs reporting a reduction: the mean number of hospitalisations per patient was 0.12 during the 12 months of follow‐up in <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>, 0.12 during one month of follow‐up in <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>, and 0.04 during the 12 months of follow‐up in <a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>; compared with 0.64, 0.21, and 0.85 in <a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>, <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>, and <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>. In <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a> there were no hospitalisations in the intervention group during the 12 months of follow‐up compared with 10% in the control group. </p> <p>In the CBA study that assessed the impact on hospitalisation in both the intervention and control groups, the number of hospitalisations per patient after 12 months did not differ between the groups (<a href="./references#CD007988-bbs2-0018" title="WengHC . Impacts of a government‐sponsored outpatient‐based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Disease Management2005;8(1):48‐58. ">Weng 2005</a>). </p> <p>Two RCTs (<a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>) and two CBA studies (<a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>; <a href="./references#CD007988-bbs2-0020" title="WindtR , GlaeskeG . Effects of a German asthma disease management program using sickness fund claims data. Journal of Asthma2010;47(6):674‐9. ">Windt 2010</a>) that reported the number of hospitalisations and ED visits as one outcome did not report any important differences between groups in the number or percentage of hospitalisations or ED visits during the study follow‐up. </p> </section> <section id="CD007988-sec-0076"> <h4 class="title">Emergency department (ED) or unscheduled visits</h4> <p>Nine studies reported the number of ED or unscheduled visits. We could not perform a meta‐analysis because the data were skewed and heterogeneous, with wide variability in means and rates at baseline; length of follow‐up from 1 to 12 months; data treated as continuous data, rate or count; and studies including ED or unscheduled visits for asthma only versus for any reason. </p> <p>Only one RCT (<a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>) showed a reduction in daytime ED visits per patient in the intervention group compared with the control group during the six month follow‐up, but no difference in night ED visits was observed. </p> <p>The results from four RCTs and one NRCT did not show any difference between groups for the number of ED or unscheduled visits for asthma per patient during 12 months of follow‐up (<a href="./references#CD007988-bbs2-0003" title="CastroM , ZimmermannNA , CrockerS , BradleyJ , LevenC , SchechtmanKB . Asthma intervention program prevents readmissions in high healthcare users. American Journal of Respiratory and Critical Care Medicine2003;168(9):1095‐9. ">Castro 2003</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>) and 1 month of follow‐up (<a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>). Another RCT showed no difference in the percentage of patients with at least one unscheduled visit after six months of follow‐up (<a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>). </p> <p>In the CBA study that assessed the impact on ED or unscheduled visits in both the intervention and control groups, there was no important reduction between groups in the number of ED visits per patient after 12 months (<a href="./references#CD007988-bbs2-0018" title="WengHC . Impacts of a government‐sponsored outpatient‐based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Disease Management2005;8(1):48‐58. ">Weng 2005</a>). </p> </section> <section id="CD007988-sec-0077"> <h4 class="title">Asthma exacerbations</h4> <p>Asthma exacerbations, which we defined as prompting hospitalisation, an ED or unscheduled medical visit, or systemic rescue glucocorticoids, were not often reported as such in the included studies. We were therefore unable to perform a meta‐analysis due to the lack of data. </p> <p><a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a> and <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a> reported the number of unscheduled visits for asthma exacerbation and the number of hospitalisations for asthma exacerbation, respectively. In <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a> the number of unscheduled visits for asthma exacerbation were comparable between groups, and in <a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a> the number of readmissions for asthma exacerbation per patient for the intervention group was less than for the control group. We could not consider the other studies reporting healthcare use as they did not specify whether the use was for asthma exacerbations. </p> <p>Finally, five studies reported oral corticosteroids use (<a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>; <a href="./references#CD007988-bbs2-0016" title="SchatzM , GibbonsC , NelleC , HardenK , ZeigerRS . Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. Journal of Asthma2006;43(3):225‐9. ">Schatz 2006</a>) but did not specify whether the use was for asthma exacerbation and data were too diverse and heterogenous to be combined. In all studies except one (<a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>), no important differences between the intervention and control groups were observed. In <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a> the percentage of days of oral steroid intake was higher in the intervention group at follow‐up (P = 0.01). </p> </section> <section id="CD007988-sec-0078"> <h4 class="title">Asthma self‐efficacy</h4> <p>Six studies reported on asthma self‐efficacy, using five different instruments: the Perceived Control of Asthma Questionnaire (PCAQ) in <a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a> and <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>, the Asthma Self‐efficacy Scale in <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>, the Chicago Initiative to Raise Asthma Health Equity Asthma Self‐Efficacy Scale in <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>, open‐ended questions measuring self‐management ability in <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>, and specific questions measuring self‐management skills in <a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a>. The first three instruments have been formerly validated but the questions used in <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a> and <a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a> have not. Data from <a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a> were excluded from this meta‐analysis because the study was a CBA and data were only available for the intervention group. </p> <p>The five studies (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>) in the meta‐analysis shown in <a href="#CD007988-fig-0006">Figure 6</a> and <a href="./references#CD007988-fig-0014" title="">Analysis 1.7</a> included a total population of 642 patients, with a follow‐up of 3 to 12 months. The pooled SMD was 0.51 (95% CI ‐0.08 to 1.11) but this difference could not be established, as a negative effect or no difference, could not be ruled out. Pooling indicated a high degree of heterogeneity (I<sup>2</sup> = 91%). </p> <div class="figure" id="CD007988-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.7 Self‐efficacy score (post‐intervention measurements)." data-id="CD007988-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.7 Self‐efficacy score (post‐intervention measurements). </p> </div> </div> </div> <p>Removing the study that used a non‐validated instrument (<a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>) did not modify the overall result (no difference between groups) or reduce the heterogeneity (pooled SMD 0.52, 95% CI ‐0.21 to 1.26; I<sup>2</sup> = 93%). No studies were at high risk of bias in this meta‐analysis. Removing the study with the most positive results (<a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>) decreased the pooled result (SMD 0.14, 95% CI ‐0.04 to 0.32) and reduced the heterogeneity (I<sup>2</sup> = 0%). </p> </section> <section id="CD007988-sec-0079"> <h4 class="title">Days off school or work absences</h4> <p>Three studies reported the impact of the intervention on days off school or work absences. <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a> reported comparable percentages of days off work in the control and intervention groups after 12 months of follow‐up. In <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a> the mean change from baseline in number of days off school or work did not differ between the intervention and control groups after 12 months of follow‐up. <a href="./references#CD007988-bbs2-0006" title="FeiferRA , VerbruggeRR , KhalidM , LevinR , O'KeefeGB , AubertRE . Improvements in asthma pharmacotherapy and self‐management: an example of a population‐based disease management program. Disease Management &amp; Health Outcomes2004;12(2):93‐102. ">Feifer 2004</a> reported the number of productivity‐loss days among employed and unemployed patients in the intervention group only. These data were not pooled because of their heterogeneous formats. </p> </section> <section id="CD007988-sec-0080"> <h4 class="title">Asthma severity</h4> <p>Seven studies reported asthma severity scores, using the Asthma Control Questionnaire (ACQ) (<a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>), the Lara Asthma Symptom Scores (LASS) (<a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>), the asthma morbidity index (<a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>), the Asthma Control Test (<a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>), the Asthma Therapy Assessment Questionnaire (ATAQ) (<a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>), and asthma symptom scores based on different questionnaires (<a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>). All instruments except those used in <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a> and <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a> had undergone validation. We adapted the instruments so that higher scores corresponded to less severe asthma for all measures. </p> <p>The main meta‐analysis included six RCTs (<a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>) with a total population of 1330 patients and a follow‐up of 6 to 12 months (see <a href="#CD007988-fig-0007">Figure 7</a>; <a href="./references#CD007988-fig-0015" title="">Analysis 1.8</a>). The pooled SMD was 0.18 in favour of CDM (95% CI 0.05 to 0.30) representing a small effect clinically (SMD &lt; 0.4). Pooling showed a low level of heterogeneity (I<sup>2</sup> = 13%). The SMD for the NRCT (<a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>), including 409 patients, was higher than the pooled SMD of the RCTs (SMD 0.47, 95% CI 0.27 to 0.66) (see <a href="#CD007988-fig-0007">Figure 7</a>; <a href="./references#CD007988-fig-0015" title="">Analysis 1.8</a>). </p> <div class="figure" id="CD007988-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.8 Asthma severity score (post‐intervention measurements)." data-id="CD007988-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.8 Asthma severity score (post‐intervention measurements). </p> </div> </div> </div> <p>Removing the two studies that used instruments that had not been formally validated (<a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>; <a href="./references#CD007988-bbs2-0017" title="SmithJR , MildenhallS , NobleMJ , ShepstoneL , KoutantjiM , MugfordM , et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax2005;60(12):1003‐11. ">Smith 2005</a>) or the study at high risk of bias (<a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>) from the meta‐analysis had little impact on the point estimate (pooled SMD 0.20, 95% CI 0.04 to 0.37; and SMD 0.17, 95% CI 0.01 to 0.33, respectively). </p> <p>Two other studies measured the percentage of patients having severe asthma (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>) and the percentage of patients without various respiratory symptoms (<a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>). In <a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a> the multilevel logistic regression model found that the odds ratios (OR) for patients to change from the 'severe' category to the 'not severe' category ('moderate' or 'mild') were almost three times higher in the intervention group than in the control group (OR 2.68, 95% CI 1.64 to 4.37). In <a href="./references#CD007988-bbs2-0015" title="PetroW , SchulenburgJM , GreinerW , WeithaseJ , SchulkeA , MetzdorfN . [Efficacy of a disease management programme in asthma] [German]. Pneumologie2005;59(2):101‐7. ">Petro 2005</a>, after 12 months of follow‐up, the median percentage of patients not presenting severe symptoms remained similar in the control group (from 44% to 46%) but increased from 46% to 81% in the intervention group. </p> </section> <section id="CD007988-sec-0081"> <h4 class="title">Use of an action plan</h4> <p>Five studies reported the percentage of patients with an action plan, but only two studies (<a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>; <a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>) provided data for both the intervention and control groups. In the first study, the percentage of patients with an asthma management plan was higher in the intervention group (27%) than in the control group (12%) at follow‐up (P &lt; 0.001) (<a href="./references#CD007988-bbs2-0011" title="LandonB E , HicksL S , O'MalleyA J , LieuT A , KeeganT , McNeilB J , et al. Improving the management of chronic disease at community health centers. New England Journal of Medicine2007;356(9):921‐34. ">Landon 2007</a>). In the second study, a greater percentage of patients in the intervention group had received an asthma action plan after 3 months of follow‐up (control group 18%; intervention group 45%) but this difference did not remain after 6 months of follow‐up (control group 23%; intervention group 20%; P = 0.17) (<a href="./references#CD007988-bbs2-0012" title="MartinM A , CatramboneC D , SharpL , EvansA , KeeR , Rucker WhitakerC , et al. The efficacy of a community asthma team intervention to improve asthma self efficacy for urban African American adults. American Thoracic Society International Conference, May 16‐21. 2008. MartinMA , CatramboneCD , KeeRA , EvansAT , SharpLK , LyttleC , et al. Improving asthma self‐efficacy: Developing and testing a pilot community‐based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology2009;123(1):153‐9. ">Martin 2009</a>). </p> </section> <section id="CD007988-sec-0082"> <h4 class="title">Patient satisfaction</h4> <p>Three studies reported outcomes on patient satisfaction. In <a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a> and <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>, patients in the intervention and control groups had similar high satisfaction scores at the end of the study. Only patients in the intervention group completed the satisfaction survey in <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>, therefore the impact of the intervention could not be assessed. </p> </section> <section id="CD007988-sec-0083"> <h4 class="title">Lung function</h4> <p>Nine studies reported outcomes on lung function: six reported the mean per cent of predicted FEV1 value (% of predicted value) (<a href="./references#CD007988-bbs2-0001" title="ArmourC , Bosnic‐AnticevichS , BrillantM , BurtonD , EmmertonL , KrassI , et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax2007;62(6):496‐502. GordoisA , ArmourC , BrillantM , Bosnic‐AnticevichS , BurtonD , EmmertonL , et al. Cost‐effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes2007;15(6):387‐96. ">Armour 2007</a>; <a href="./references#CD007988-bbs2-0004" title="CharroisT , NewmanS , SinD , SenthilselvanA , TsuyukiRT . Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Controlled Clinical Trials2004;25(5):502‐14. [PUBMED: 15465619] CharroisTL , NewmanSC , SenthilselvanA , TsuyukiRT . Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Canadian Pharmacists Journal2006;139(4):44‐50. ">Charrois 2006</a>; <a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>) and five reported the PEF rate, reported as L/min in three studies (<a href="./references#CD007988-bbs2-0008" title="HerborgH , SoendergaardB , FroekjaerB , FonnesbaekL , JorgensenT , HeplerCD , et al. Improving drug therapy for patients with asthma‐‐part 1: Patient outcomes [see comments]. Journal of the American Pharmaceutical Association2001;41(4):539‐50. HerborgH , SoendergaardB , JorgensenT , FonnesbaekL , HeplerCD , HolstH , et al. Improving drug therapy for patients with asthma‐part 2: Use of antiasthma medications. Journal of the American Pharmaceutical Association2001;41(4):551‐9. [PUBMED: 11486981] ">Herborg 2001</a>; <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>) and as per cent of predicted value in two studies (<a href="./references#CD007988-bbs2-0007" title="GalbreathAD , SmithB , WoodPR , InscoreS , ForknerE , VazquezM , et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Annals of Allergy, Asthma and Immunology2008;101(6):599‐607. PetersJI , McKinneyJM , SmithB , WoodP , ForknerE , GalbreathAD . Impact of obesity in asthma: evidence from a large prospective disease management study. Annals of Allergy, Asthma and Immunology2011;106(1):30‐5. ">Galbreath 2008</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>). </p> <p>We combined data from the eight RCTs in one meta‐analysis using the SMD, including a population of 1559 patients, with a follow‐up of 6 to 12 months (<a href="./references#CD007988-fig-0016" title="">Analysis 1.9</a>). Overall, the pooled SMD for lung function was 0.19 in favour of CDM (95% CI 0.09 to 0.30). This SMD (small effect size if SMD &lt; 0.4) corresponded to a difference, on the predicted FEV1 % scale, of 5.0%. There was no heterogeneity (I<sup>2</sup> = 0%). In the FEV1 subgroup, the SMD was 0.16 (95% CI 0.05 to 0.27). In the PEF (L/min) and PEF (% predicted) subgroups, which only included one study each, the SMD was 0.30 (95% CI 0.03 to 0.56) and 0.53 (95% CI ‐0.01 to 1.06), respectively. </p> <p>Removing the study at high risk of bias (<a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>) from the meta‐analysis did not affect the SMD (SMD 0.18, 95% CI 0.06 to 0.29). </p> <p>We also looked at the impact of CDM on these three different measures of lung function in three separate meta‐analyses (<a href="./references#CD007988-fig-0017" title="">Analysis 1.10</a>; <a href="./references#CD007988-fig-0018" title="">Analysis 1.11</a>; <a href="./references#CD007988-fig-0019" title="">Analysis 1.12</a>), allowing us to use the MD. For FEV1, the MD for the predicted value was 2.81% in favour of CDM (95% CI 0.99 to 4.64). For PEF, the pooled MD was 33.52 L/min in favour of CDM (95% CI 11.38 to 55.65) for RCTs and the MD was 30.52 L/min (95% CI 7.46 to 53.58) for the NRCT. For PEF in predicted % values, the MD was 8.68% in favour of CDM (95% CI 3.73 to 13.63). </p> </section> <section id="CD007988-sec-0084"> <h4 class="title">Subgroup analyses</h4> <p>We performed subgroup analyses for two outcomes with sufficient studies: asthma‐specific quality of life (<a href="./references#CD007988-fig-0009" title="">Analysis 1.2</a>; <a href="./references#CD007988-fig-0010" title="">Analysis 1.3</a>; <a href="./references#CD007988-fig-0011" title="">Analysis 1.4</a>) and lung function (<a href="./references#CD007988-fig-0020" title="">Analysis 1.13</a>; <a href="./references#CD007988-fig-0021" title="">Analysis 1.14</a>; <a href="./references#CD007988-fig-0022" title="">Analysis 1.15</a>). The results from these analyses did not show any differences in the impact of the intervention as a function of its comprehensiveness, the dominant component of the intervention, or the presence of limited CDM components in the control group. </p> </section> <section id="CD007988-sec-0085"> <h4 class="title">Additional sensitivity analyses</h4> <p>Similar results were observed when a fixed‐effect model rather than a random‐effects model was used, and when studies with imputed SDs (<a href="./references#CD007988-bbs2-0005" title="CouturaudF , ProustA , FrachonI , DewitteJD , OgerE , QuiotJJ , et al. Education and self‐management: a one‐year randomized trial in stable adult asthmatic patients. Journal of Asthma2002;39(6):493‐500. ">Couturaud 2002</a>; <a href="./references#CD007988-bbs2-0010" title="KokubuF , NakajimaS , ItoK , MakinoS , KitamuraS , FukuchiY , et al. Hospitalization reduction by an asthma tele‐medicine system. Arerugi ‐ Japanese Journal of Allergology2000;49(1):19‐31. KokubuF , SuzukiH , SanoY , KiharaN , AdachiM . Tele‐medicine system for high‐risk asthmatic patients. Arerugi ‐ Japanese Journal of Allergology1999;48(7):700‐12. ">Kokubu 2000</a>; <a href="./references#CD007988-bbs2-0014" title="McLeanW , GillisJ , WallerR . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal2003;10(4):195. ">McLean 2003</a>) or SDs estimated from a graph (<a href="./references#CD007988-bbs2-0019" title="WilsonSR , StrubP , BuistAS , KnowlesSB , LavoriPW , LapidusJ , et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine2010;181(6):566‐77. ">Wilson 2010</a>) were excluded. </p> <p>The available data allowed us to analyse the change from baseline measurements instead of post‐intervention measurements for asthma‐specific quality of life (<a href="./references#CD007988-fig-0013" title="">Analysis 1.6</a>). The pooled SMD from the seven RCTs including 1547 patients (SMD 0.30, 95% CI 0.18 to 0.43) was higher than in the meta‐analysis with post‐intervention measures, although it did not reach clinical significance (SMD &lt; 0.4), and heterogeneity (I<sup>2</sup> = 25%) was lower. The SMD for the NRCT including 413 patients was similar to the pooled SMD of RCTs (SMD 0.37, 95% CI 0.18 to 0.57). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007988-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007988-sec-0086">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007988-sec-0128">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007988-sec-0086"></div> <section id="CD007988-sec-0087"> <h3 class="title" id="CD007988-sec-0087">Summary of main results</h3> <p>We reviewed the results from 20 studies that assessed the effectiveness of chronic disease management for adults with asthma. Results from the meta‐analyses showed that CDM programmes probably improve asthma‐specific quality of life (SMD 0.22, 95% CI 0.08 to 0.37), asthma severity scores (SMD 0.18, 95% CI 0.05 to 0.30), and lung function tests (SMD 0.19, 95% CI 0.09 to 0.30) but the results were inconclusive for self‐efficacy (SMD 0.51, 95% CI ‐0.08 to 1.11). </p> <p>We could not combine data for hospitalisations and ED or unscheduled visits in a meta‐analysis because the data were skewed and too heterogenous; overall, the results from the individual studies were inconclusive. In addition, the data for the effectiveness on asthma exacerbations, days off work or school, use of an action plan, and patient satisfaction were sparse and meta‐analyses could not be performed. Although there were many different secondary outcomes in the included studies, only one study reported data on adverse events or mortality (<a href="./references#CD007988-bbs2-0013" title="MayoPH , RichmanJ , HarrisHW . Results of a program to reduce admissions for adult asthma [see comment]. Annals of Internal Medicine1990;112(11):864‐71. ">Mayo 1990</a>). In this study, during the eight months of follow‐up, there were no asthma‐related deaths in the intervention group but one patient died from asthma in the control group. </p> <p>We did not observe any differences for the effectiveness of the intervention as a function of three pre‐specified features of the intervention: comprehensiveness of the intervention, the dominant component of the intervention, and presence of limited CDM components. </p> <p>The seven clinically most important primary outcomes are summarised in the <a href="./full#CD007988-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD007988-sec-0088"> <h3 class="title" id="CD007988-sec-0088">Overall completeness and applicability of evidence</h3> <p>We can reasonably consider that the results of this systematic review reflect what has been published on the effectiveness of CDM programmes in asthma. The 20 studies included in this review were identified after applying a comprehensive search strategy designed to identify interventions that met all five criteria of an operational definition of chronic disease management (that is, including at least one organisational component targeting patients, at least one organisational component targeting healthcare professionals or the healthcare system, patient education or self‐management support, active involvement of two or more healthcare professionals in patient care, and a minimum duration of three months). </p> <p>We pre‐specified the 10 most relevant outcomes for people with asthma as primary outcomes for this systematic review. The studies all reported at least one of these 10 primary outcomes (average of seven primary and secondary outcomes per study) and a meta‐analysis could be performed for 4 out of these 10 outcomes, guaranteeing the relevance of our results. However, since the number of studies included in each meta‐analysis was rather low, except for the outcomes asthma‐specific quality of life and lung function (eight studies each), we were unable to conduct appropriate subgroup analyses or meta‐regression. </p> <p>However, although we included study designs other than RCTs (that is, NRCTs, CBAs, and ITS), 49 studies had to be excluded because their design was considered to be at high risk of bias (for example, several CBA studies with only one control or intervention site rather than at least two control and two intervention sites as specified by the EPOC review group methodology). In addition, none of the four included CBAs with two control and two intervention groups could be included in the meta‐analyses because available data were incomplete or inappropriate. Although these excluded studies were not considered to be relevant in the assessment of the effectiveness of CDM programmes, it might be useful to investigate what data these studies could contribute to the development of CDM programmes, in terms of understanding which key components bring most benefits or in improving our knowledge about the contexts and settings where these programmes have been implemented. </p> <p>The results of this review should be considered with caution since we observed statistical, clinical, and methodological heterogeneity. This heterogeneity was taken into account in the choice of statistical models used and in the assessment of the level of the evidence. </p> </section> <section id="CD007988-sec-0089"> <h3 class="title" id="CD007988-sec-0089">Quality of the evidence</h3> <p>We included 20 studies, 15 of which were RCTs, in this review, and included up to eight studies and 1627 patients in the meta‐analyses. Sensitivity analyses based on study quality (excluding studies at high risk of bias or with imputed SDs) did not change the direction, significance, or magnitude of the observed effectiveness. </p> <p>Following the GRADE approach, we specified the levels of quality of the evidence (high, moderate, low, and very low) for the seven most important primary outcomes presented in our <a href="./full#CD007988-tbl-0001">summary of findings Table for the main comparison</a>. This was done taking into account the study design, indirectness of the evidence, unexplained heterogeneity or inconsistency of the results, imprecision of the results, and high probability of publication bias. </p> <p>Overall, the quality of the evidence was moderate to low despite the fact that studies for which a meta‐analysis could be performed were mostly RCTs. This was due mainly to study design limitations, which resulted in either unclear or high risk of bias in most cases, and in wide confidence intervals, therefore explaining why the level of evidence was downgraded by one or two levels depending on the outcomes. </p> </section> <section id="CD007988-sec-0090"> <h3 class="title" id="CD007988-sec-0090">Potential biases in the review process</h3> <p>We attempted to minimise biases in our review process by firstly using an explicit and detailed operational definition of what we considered as CDM to overcome the absence of a consensual definition of chronic disease management and help the reader understand which types of programmes were considered in this review. This definition included more than the traditional education and self‐management components evaluated previously in primary studies and a few systematic reviews. Secondly, we restricted study designs to those recommended by the EPOC Review Group methodology (<a href="./references#CD007988-bbs2-0171" title="EffectivePractice , Organisation of Care(EPOC) . What study designs should be included in an EPOC review and what should they be called? EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services 2013. Available at: http://epocoslo.cochrane.org/epoc‐specific‐resources‐review‐authors. Accessed on 18 May 2014. ">EPOC 2013</a>), which meant that CBA studies had to assess two intervention and two control groups. Finally, we performed a comprehensive search for primary studies. </p> <p>The results of this systematic review should be interpreted considering the following limitations. As with most systematic reviews targeting complex interventions, such as CDM, several sources of heterogeneity must be acknowledged. In addition to methodological and statistical heterogeneity, the biggest source of heterogeneity was clinical heterogeneity due to context, settings, patients, and interventions, which differed across studies. We attempted to limit this clinical heterogeneity by having a clear operational definition and only including comprehensive interventions. In addition, heterogeneity was taken into consideration in the statistical analyses by using random‐effects models and in the quality evaluation of the studies, which resulted in downgrading in some cases. Despite this, a high level of unexplained statistical heterogeneity remained in the self‐efficacy meta‐analysis, which was mainly due to one study (<a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a>) that included a higher proportion of men than the other studies. However, as other outcomes from this study did not stand out in the other meta‐analyses it is unlikely that the large positive results of this study were due to intervention or population characteristics. The atypical result for <a href="./references#CD007988-bbs2-0009" title="HuangTT , LiYT , WangCH . Individualized programme to promote self‐care among older adults with asthma: randomized controlled trial. Journal of Advanced Nursing2009;65(2):348‐58. ">Huang 2009</a> could also be due to the self‐efficacy instrument used in this study, which was different from the other studies. Despite having included 20 studies in the review, only eight at most could be included in the meta‐analyses because of missing information and the wide range of outcomes reported in the different studies, which were too heterogeneous to be combined in some cases. Further, three of the outcomes (quality of life, self‐efficacy, asthma severity) were self‐reported by patients. However, patient reported outcome measures are increasingly being measured in evaluations of CDM programmes, because they are important to patients. Most instruments used in the included studies have been validated. Only two of the four studies that used an instrument that had not been validated contributed data to a meta‐analysis, and sensitivity analyses excluding these two studies did not modify the pooled estimate. Finally, there was often little information about the components of the interventions, their frequency and intensity for example, as well as the specific setting and context in which they were implemented, making their reproducibility in other settings difficult. However, this is inherent to CDM and, more generally, other quality improvement interventions, which are complex and context‐dependent (<a href="./references#CD007988-bbs2-0160" title="DavidoffF , BataldenP , StevensD , OgrincG , MooneySE . Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project. BMJ (Clinical research ed.)2009;338:a3152. [PUBMED: 19153129] ">Davidoff 2009</a>). </p> </section> <section id="CD007988-sec-0091"> <h3 class="title" id="CD007988-sec-0091">Agreements and disagreements with other studies or reviews</h3> <p>This review updates three previous systematic reviews assessing the effectiveness of CDM programmes in patients with asthma (<a href="./references#CD007988-bbs2-0197" title="LemmensKM , NieboerAP , HuijsmanR . A systematic review of integrated use of disease‐management interventions in asthma and COPD. Respiratory Medicine2009;103(5):670‐91. [PUBMED: 19155168] ">Lemmens 2009</a>; <a href="./references#CD007988-bbs2-0200" title="MaciejewskiML , ChenSY , AuDH . Adult asthma disease management: an analysis of studies, approaches, outcomes, and methods. Respiratory Care2009;54(7):878‐86. [PUBMED: 19558739] ">Maciejewski 2009</a>; <a href="./references#CD007988-bbs2-0225" title="SteutenL , LemmensK , VrijhoefB . Health technology assessment of asthma disease management programs. Current Opinion in Allergy and Clinical Immunology2007;7(3):242‐8. ">Steuten 2007a</a>). The main differences between our review and the previous reviews are that i) our search strategy was more comprehensive and detailed, and did not have any restrictions for publication year, as did <a href="./references#CD007988-bbs2-0225" title="SteutenL , LemmensK , VrijhoefB . Health technology assessment of asthma disease management programs. Current Opinion in Allergy and Clinical Immunology2007;7(3):242‐8. ">Steuten 2007a</a>, thus giving a broader coverage of the intervention over time and more potential articles to screen, ii) the use of an a priori proposed operational definition of CDM, defined in the published protocol, which enabled the criteria for selecting studies to be clearer, and iii) the study designs considered in the current review included all those recommended by the EPOC group as being able to minimise potential bias (<a href="./references#CD007988-bbs2-0171" title="EffectivePractice , Organisation of Care(EPOC) . What study designs should be included in an EPOC review and what should they be called? EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services 2013. Available at: http://epocoslo.cochrane.org/epoc‐specific‐resources‐review‐authors. Accessed on 18 May 2014. ">EPOC 2013</a>). However, despite these differences, our results are consistent with previous reviews, that is small overall effects, improved quality of life (<a href="./references#CD007988-bbs2-0197" title="LemmensKM , NieboerAP , HuijsmanR . A systematic review of integrated use of disease‐management interventions in asthma and COPD. Respiratory Medicine2009;103(5):670‐91. [PUBMED: 19155168] ">Lemmens 2009</a>), no effect on emergency department (ED) visits (<a href="./references#CD007988-bbs2-0197" title="LemmensKM , NieboerAP , HuijsmanR . A systematic review of integrated use of disease‐management interventions in asthma and COPD. Respiratory Medicine2009;103(5):670‐91. [PUBMED: 19155168] ">Lemmens 2009</a>), and limited impact on lung function (<a href="./references#CD007988-bbs2-0197" title="LemmensKM , NieboerAP , HuijsmanR . A systematic review of integrated use of disease‐management interventions in asthma and COPD. Respiratory Medicine2009;103(5):670‐91. [PUBMED: 19155168] ">Lemmens 2009</a>; <a href="./references#CD007988-bbs2-0225" title="SteutenL , LemmensK , VrijhoefB . Health technology assessment of asthma disease management programs. Current Opinion in Allergy and Clinical Immunology2007;7(3):242‐8. ">Steuten 2007a</a>). </p> <p>There are several explanations why we found little effect of CDM programmes in patients with asthma. First, the 'usual care' administered to the control group may have differed between studies and may have included some asthma education initiatives; since this has been considered as standard care of patients with asthma for a long time and reflects a good level of clinical management. Therefore, it may be difficult to demonstrate a difference of effect between a CDM programme and what is described as usual care. Second, the CDM programmes assessed in this systematic review were quite heterogeneous, therefore constituting a heterogeneous pooled intervention group that was compared with usual care, which was also heterogeneous, resulting in pooled odds ratios (ORs) tending towards a null effect. Third, the prevalence of asthma varies between countries, and heterogeneity in its diagnosis, severity, and phenotypes has been reported (<a href="./references#CD007988-bbs2-0167" title="EderW , EgeMJ , vonMutiusE . The asthma epidemic. The New England Journal of Medicine2006;355(21):2226‐35. [PUBMED: 17124020] ">Eder 2006</a>). CDM could therefore be effective for only a subgroup of patients with asthma. Fourth, the length of key components and follow‐up periods may have been too short to allow the effects of long‐term interventions to be detected. Finally, demonstrating differences for outcomes that are not so frequent in the daily life of patients with asthma, such as hospitalisation and emergency or unscheduled visits, may be difficult. </p> <p>The results of this review, showing trends towards some benefits for patients with asthma, are consistent with those from other systematic reviews assessing CDM programmes for different chronic diseases such as COPD (<a href="./references#CD007988-bbs2-0193" title="KruisAL , SmidtN , AssendelftWJ , GusseklooJ , BolandMR , Rutten‐van MolkenM , et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews2013;10:CD009437. [PUBMED: 24108523] ">Kruis 2013</a>; <a href="./references#CD007988-bbs2-0198" title="LemmensKM , LemmensLC , BoomJH , DrewesHW , MeeuwissenJA , SteutenLM , et al. Chronic care management for patients with COPD: a critical review of available evidence. Journal of Evaluation in Clinical Practice2013;19(5):734‐52. [PUBMED: 22133473] ">Lemmens 2013</a>; <a href="./references#CD007988-bbs2-0211" title="NiesinkA , TrappenburgJCA , deWeert‐vanOGH , LammersJWJ , VerheijTJM , SchrijversAJP . Systematic review of the effects of chronic disease management on quality‐of‐life in people with chronic obstructive pulmonary disease. Respiratory Medicine2007;101(11):2233‐9. ">Niesink 2007</a>; <a href="./references#CD007988-bbs2-0216" title="Peytremann‐BridevauxI , StaegerP , BridevauxPO , GhaliWA , BurnandB . Effectiveness of chronic obstructive pulmonary disease‐management programs: systematic review and meta‐analysis. The American Journal of Medicine2008;121(5):433‐43.e4. ">Peytremann‐Bridevaux 2008</a>), diabetes (<a href="./references#CD007988-bbs2-0169" title="ElissenAM , SteutenLM , LemmensLC , DrewesHW , LemmensKM , MeeuwissenJA , et al. Meta‐analysis of the effectiveness of chronic care management for diabetes: investigating heterogeneity in outcomes. Journal of Evaluation in Clinical Practice2013;19(5):753‐62. [PUBMED: 22372830] ">Elissen 2013</a>; <a href="./references#CD007988-bbs2-0192" title="KnightK , BadamgaravE , HenningJM , HasselbladV , GanoAD , OfmanJJ , et al. A systematic review of diabetes disease management programs. The American Journal of Managed Care2005;11(4):242‐50. ">Knight 2005</a>; <a href="./references#CD007988-bbs2-0212" title="NorrisSL , NicholsPJ , CaspersenCJ , GlasgowRE , EngelgauMM , JackL , et al. The effectiveness of disease and case management for people with diabetes. A systematic review. American Journal of Preventive Medicine2002;22(4 Suppl):15‐38. ">Norris 2002</a>; <a href="./references#CD007988-bbs2-0219" title="PimouguetC , LeGoffM , ThiebautR , DartiguesJF , HelmerC . Effectiveness of disease‐management programs for improving diabetes care: a meta‐analysis. CMAJ: Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne2011;183(2):E115‐27. [PUBMED: 21149524] ">Pimouguet 2011</a>), heart failure (<a href="./references#CD007988-bbs2-0183" title="GohlerA , JanuzziJL , WorrellSS , OsterzielKJ , GazelleGS , DietzR , et al. A systematic meta‐analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. Journal of Cardiac Failure2006;12(7):554‐67. [PUBMED: 16952790] ">Gohler 2006</a>; <a href="./references#CD007988-bbs2-0184" title="GonsethJ , Guallar‐CastillónP , BanegasJR , Rodríguez‐ArtalejoF . The effectiveness of disease management programmes in reducing hospital re‐admission in older patients with heart failure: a systematic review and meta‐analysis of published reports. European Heart Journal2004;25(18):1570‐95. ">Gonseth 2004</a>; <a href="./references#CD007988-bbs2-0203" title="McAlisterFA , LawsonFM , TeoKK , ArmstrongPW . A systematic review of randomized trials of disease management programs in heart failure. The American Journal of Medicine2001;110(5):378‐84. ">McAlister 2001</a>; <a href="./references#CD007988-bbs2-0222" title="RoccaforteR , DemersC , BaldassarreF , TeoKK , YusufS . Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta‐analysis. European Journal of Heart Failure2005;7(7):1133‐44. ">Roccaforte 2005</a>), and depression (<a href="./references#CD007988-bbs2-0154" title="BadamgaravE , WeingartenSR , HenningJM , KnightK , HasselbladV , GanoA , et al. Effectiveness of disease management programs in depression: a systematic review. The American Journal of Psychiatry2003;160(12):2080‐90. ">Badamgarav 2003</a>; <a href="./references#CD007988-bbs2-0210" title="Neumeyer‐GromenA , LampertT , StarkK , KallischniggG . Disease management programs for depression: a systematic review and meta‐analysis of randomized controlled trials. Medical Care2004;42(12):1211‐21. ">Neumeyer‐Gromen 2004</a>). CDM programmes seem to be less effective in asthma patients, however. In addition to the factors which may have led to underestimation of the effect of CDM in our analysis discussed above, other methodological issues could explain little effectiveness. As previously reported (<a href="./references#CD007988-bbs2-0197" title="LemmensKM , NieboerAP , HuijsmanR . A systematic review of integrated use of disease‐management interventions in asthma and COPD. Respiratory Medicine2009;103(5):670‐91. [PUBMED: 19155168] ">Lemmens 2009</a>), the quality of the studies assessing the effect of CDM for patient with asthma is suboptimal, and RCTs can be difficult to conduct in the community, a setting where patients with asthma often receive their care. Also, evaluation measures were often not pertinent and focused on outcomes rather than processes or structure measures (<a href="./references#CD007988-bbs2-0225" title="SteutenL , LemmensK , VrijhoefB . Health technology assessment of asthma disease management programs. Current Opinion in Allergy and Clinical Immunology2007;7(3):242‐8. ">Steuten 2007a</a>). Other explanations for a smaller effect in asthma, compared with other chronic diseases, may relate to the disease itself or its treatment since, compared with other common chronic diseases, asthma generally affects younger and otherwise healthy patients; and is observed as respiratory symptoms only. It could therefore be hypothesised that interventions limited to education or self‐management, or both, which primarily target the appropriate use of drugs and avoidance of triggers and which were frequently offered in the control groups of this review may be sufficient. However, there have been few published systematic reviews assessing the effectiveness of education or self‐management interventions despite there being a large number of primary studies. These interventions have been shown to greatly vary and be insufficiently documented (<a href="./references#CD007988-bbs2-0227" title="SudreP , JacquemetS , UldryC , PernegerTV . Objectives, methods and content of patient education programmes for adults with asthma: systematic review of studies published between 1979 and 1998. Thorax1999;54(8):681‐7. [PUBMED: 10413719] ">Sudre 1999</a>). However, it is generally accepted that while patient education programmes limited to information only do not improve health outcomes (<a href="./references#CD007988-bbs2-0179" title="GibsonPG , PowellH , CoughlanJ , WilsonA , HensleyMJ , AbramsonMJ , et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database of Systematic Reviews2002, Issue 2. [DOI: 10.1002/14651858.CD001005] ">Gibson 2002</a>), self‐management education programmes associated with regular practitioner review do (<a href="./references#CD007988-bbs2-0180" title="GibsonPG , PowellH , CoughlanJ , WilsonA , AbramsonMJ , HaywoodP , et al. Self‐management education and regular practitioner review for adults with asthma. Cochrane Database of Systematic Reviews2002, Issue 3. [DOI: 10.1002/14651858.CD001117] ">Gibson 2003</a>). In our review, results of the exploratory subgroup analyses on the dominant component and the comprehensiveness of the implemented interventions were inconclusive. For patients with asthma, it is unknown if implementing interventions such as CDM programmes provides more benefit than education and self‐management support only. </p> <p>The effects of CDM programmes for asthma can be contrasted to the effects of those programmes targeting patients with COPD, an obstructive disease characterised by respiratory symptoms and systemic consequences of chronic inflammation that affects older patients, where recent good quality evidence has confirmed the benefits of CDM programmes in terms of quality of life, hospitalisation, and exercise tolerance (<a href="./references#CD007988-bbs2-0193" title="KruisAL , SmidtN , AssendelftWJ , GusseklooJ , BolandMR , Rutten‐van MolkenM , et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews2013;10:CD009437. [PUBMED: 24108523] ">Kruis 2013</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007988-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram." data-id="CD007988-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Description of intervention components by study." data-id="CD007988-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Description of intervention components by study.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007988-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007988-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.1 Asthma‐specific quality of life score (post‐intervention measurements)." data-id="CD007988-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.1 Asthma‐specific quality of life score (post‐intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.7 Self‐efficacy score (post‐intervention measurements)." data-id="CD007988-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.7 Self‐efficacy score (post‐intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.8 Asthma severity score (post‐intervention measurements)." data-id="CD007988-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chronic disease management programme versus usual care, outcome: 1.8 Asthma severity score (post‐intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 1 Asthma‐specific quality of life score (post intervention measurements)." data-id="CD007988-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 1 Asthma‐specific quality of life score (post intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 2 Subgroup analysis asthma‐specific quality of life score according to the comprehensiveness of the intervention (≥ 8 / &lt; 8 components)." data-id="CD007988-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 2 Subgroup analysis asthma‐specific quality of life score according to the comprehensiveness of the intervention (≥ 8 / &lt; 8 components). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 3 Subgroup analysis asthma‐specific quality of life score according to the dominant component of the intervention." data-id="CD007988-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 3 Subgroup analysis asthma‐specific quality of life score according to the dominant component of the intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 4 Subgroup analysis asthma‐specific quality of life score according to the presence of limited CDM components in the control group." data-id="CD007988-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 4 Subgroup analysis asthma‐specific quality of life score according to the presence of limited CDM components in the control group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 5 Subgroup analysis asthma‐specific quality of life score according to QOL scale." data-id="CD007988-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 5 Subgroup analysis asthma‐specific quality of life score according to QOL scale. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 6 Sensitivity analysis asthma‐specific quality of life (change from baseline measurements)." data-id="CD007988-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 6 Sensitivity analysis asthma‐specific quality of life (change from baseline measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-07.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 7 Self‐efficacy score (post intervention measurements)." data-id="CD007988-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 7 Self‐efficacy score (post intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-08.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 8 Asthma severity score (post intervention measurements)." data-id="CD007988-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 8 Asthma severity score (post intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 9 Lung function (FEV1 and PEF) (post intervention measurements)." data-id="CD007988-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 9 Lung function (FEV1 and PEF) (post intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 10 FEV1 (% predicted) (post intervention measurements)." data-id="CD007988-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 10 FEV1 (% predicted) (post intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 11 PEF (L/min) (post intervention measurements)." data-id="CD007988-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 11 PEF (L/min) (post intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 12 PEF (% predicted) (post intervention measurements)." data-id="CD007988-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 12 PEF (% predicted) (post intervention measurements). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 13 Subgroup analysis lung function according to the comprehensiveness of the intervention (≥ 8 / &lt; 8 components)." data-id="CD007988-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 13 Subgroup analysis lung function according to the comprehensiveness of the intervention (≥ 8 / &lt; 8 components). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 14 Subgroup analysis lung function according to the dominant component of the intervention." data-id="CD007988-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 14 Subgroup analysis lung function according to the dominant component of the intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007988-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/urn:x-wiley:14651858:media:CD007988:CD007988-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_t/tCD007988-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chronic disease management programme versus usual care, Outcome 15 Subgroup analysis lung function according to the presence of limited CDM components in the control group." data-id="CD007988-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Chronic disease management programme versus usual care, Outcome 15 Subgroup analysis lung function according to the presence of limited CDM components in the control group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/media/CDSR/CD007988/image_n/nCD007988-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007988-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Chronic disease management compared with usual care for adults with asthma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Chronic disease management compared with usual care for adults with asthma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with asthma<br/> <b>Settings:</b> 7 studies in primary care practices, 3 in outpatient hospital departments, 3 in pharmacies, 2 in health maintenance organisations (HMOs), 5 in mixed settings<br/> <b>Intervention:</b> chronic disease management<br/> <b>Comparison:</b> usual care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Usual care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Chronic disease management </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma‐specific quality of life score</b> <br/> Measured on different scales in different studies. Higher scores indicate higher quality of life.<br/> Follow‐up: 3 to 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean asthma‐specific quality of life score ranged across control groups from<br/> <b>3.8 to 5.3</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean asthma‐specific quality of life score in the intervention groups was<br/> <b>0.22 standard deviations higher</b> <br/> (0.08 to 0.37 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1627<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A SMD of 0.22 represents a small improvement in quality of life. On the AQLQ scale, it represents a mean difference of 0.31 (0.11 to 0.53). MCID of AQLQ = 0.5<sup>3,4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of hospitalisations per patient</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of hospitalisations per patient ranged across control groups from <b>0.06 to 1.23</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of hospitalisations per patient ranged across intervention groups from <b>0.02 to 0.4</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed;see comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data too heterogeneous to perform meta‐analysis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of emergency room or unscheduled visits</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of emergency room or unscheduled visits per patient ranged across control groups from <b>0.02 to 1.4</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of emergency room or unscheduled visits per patient ranged across intervention groups from <b>0.02 to 1.9</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed; see comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data too heterogeneous to perform meta‐analysis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma exacerbations</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed;see comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for meta‐analysis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐efficacy score</b><sup>5</sup> <br/> Measured on different scales in different studies. Higher scores indicate higher self‐efficacy<br/> Follow‐up: 3 to 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><sup>5</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐efficacy score in the intervention groups was<br/> <b>0.51 standard deviations higher</b> <br/> (0.08 lower to 1.11 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>642<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A SMD of 0.51 represents a moderate improvement in self‐efficacy<sup>3,8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma severity score</b><sup>5</sup> <br/> Measured on different scales in different studies. Higher scores indicate lower severity<br/> Follow‐up: 6‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean asthma severity score in the intervention groups was<br/> <b>0.18 standard deviations higher</b> <br/> (0.05 to 0.3 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1330<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>6,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A SMD of 0.18 represents a small improvement in asthma severity&lt;BR/&gt;<sup>3,8</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Days off work</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed;see comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for meta‐analysis</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Values correspond to the AQLQ scores only<br/> <sup>2</sup> Downgraded because majority of studies were at high or unclear risk of bias<br/> <sup>3</sup> As a rule of thumb: SMD &lt; 0.40 = small effect, SMD 0.40 to 0.70 = moderate effect, SMD &gt; 0.70 = large effect<br/> <sup>4</sup> The score was estimated using a SD of 1.43 (control group of Gallbreath's study)<br/> <sup>5</sup> No assumed risk presented for usual groups because too much variation in the instruments or scales used<br/> <sup>6</sup> Downgraded because of clinical, statistical and measurement heterogeneity<br/> <sup>7</sup> Wide 95% CIs<br/> <sup>8</sup> Back‐transformation was not performed because all studies used another instrument or scale<br/> <sup>9</sup> Downgraded because three studies were at high risk of bias </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Chronic disease management compared with usual care for adults with asthma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007988-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of characteristics of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Design (allocation)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country and setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention name, duration, number of components, dominant component</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patients in intervention group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patients in control group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of reported outcomes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCTs</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Armour 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C‐RCT</p> <p>(pharmacy)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> <p>rural and urban pharmacies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacy Asthma Care Program</p> <p>6 months</p> <p>components: 8</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 160</p> <p>women: 67.5%</p> <p>mean age: 47.5</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 186</p> <p>women: 60.5%</p> <p>mean age: 50.4</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org: 1</p> <p>Process: 6</p> <p>QOL: 1</p> <p>Symptoms/activity: 2</p> <p>Self‐care: 5</p> <p>Lung function: 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cambach 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Netherlands</p> <p>local physiotherapy</p> <p>practices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rehabilitation programme</p> <p>3 months</p> <p>components: 6</p> <p>dominant component: ORG_PT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 22</p> <p>women: 81.8%</p> <p>mean age: 40</p> <p>mild‐moderate asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 21</p> <p>women: 66.7%</p> <p>mean age: 53</p> <p>mild‐moderate asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>QOL: 1</p> <p>Symptoms/activity: 3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Castro 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>inpatients and outpatients</p> <p>in a hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Use of an asthma nurse specialist to provide a multifaceted approach to</p> <p>asthma care for “high‐risk” inpatients</p> <p>6 months</p> <p>components: 10</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 50</p> <p>women: 80%</p> <p>mean age: 35</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 46</p> <p>women: 85%</p> <p>mean age: 38</p> <p>mod‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 8</p> <p>QOL: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Charrois 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada</p> <p>community rural pharmacies and PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Better Respiratory Education and Asthma Treatment in Hinton and Edson (BREATHE)</p> <p>6 months</p> <p>components: 11</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 36</p> <p>women: 53%</p> <p>mean age: 35.7</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 34</p> <p>women: 53%</p> <p>mean age: 38.7</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org: 1</p> <p>Process: 3</p> <p>HC use: 1</p> <p>Symptoms/activity: 2</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Couturaud 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>France</p> <p>outpatient clinic of two university hospitals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Educational programme in asthmatic patients following treatment readjustment</p> <p>12 months</p> <p>components: 7</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 26</p> <p>women: 69.4%</p> <p>mean age: 37.8</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 28</p> <p>women: 66.7%</p> <p>mean age: 38.1</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 1</p> <p>QOL:1</p> <p>Symptoms/activity: 3</p> <p>Self‐care: 3</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Galbreath 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>University Medical Center</p> <p>and PCP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The South Texas Asthma Management Project (STAMP)</p> <p>6 months</p> <p>components: 9</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 262</p> <p>women: 77.6%</p> <p>mean age: 42.3</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 124</p> <p>women: 77.6%</p> <p>mean age: 43.7</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org: 1</p> <p>Process: 2</p> <p>HC use: 4</p> <p>QOL: 1</p> <p>Symptoms/activity: 2</p> <p>Lung function: 3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Huang 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan</p> <p>outpatient chest department</p> <p>of hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individualised self‐care education programme</p> <p>6 months</p> <p>components: 6</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 98</p> <p>women: 29.5%</p> <p>mean age: na</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 50</p> <p>women: 22%</p> <p>mean age: na</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 1</p> <p>HC use: 1</p> <p>Symptoms/activity: 2</p> <p>Self‐care: 3</p> <p>Lung function: 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kokubu 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Japan</p> <p>hospital and patients' home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asthma telemedicine system</p> <p>6 months</p> <p>components: 8</p> <p>dominant component: ORG_HC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 32</p> <p>women: 62%</p> <p>mean age: 49.9</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 34</p> <p>women: 56%</p> <p>mean age: 47.3</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 4</p> <p>Pt satis: 1</p> <p>QOL: 1</p> <p>Symptoms/activity: 3</p> <p>Self‐care: 3</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Martin 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A community‐based intervention to improve asthma self‐efficacy in African</p> <p>American adults designed by the Chicago Initiative to Raise Asthma</p> <p>Health Equity (CHIRAH)</p> <p>3 months</p> <p>components: 7</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 19</p> <p>women: 60%</p> <p>mean age: 33</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 18</p> <p>women: 77%</p> <p>mean age: 37</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org: 1</p> <p>Process: 2</p> <p>QOL: 1</p> <p>Symptoms/activity: 3</p> <p>Self‐care: 3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mayo 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>outpatient chest clinic of a hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outpatient programme designed to reduce readmissions for asthma exacerbations</p> <p>8 months</p> <p>components: 6</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 47</p> <p>women: 70.2%</p> <p>mean age: 42</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 57</p> <p>women: 57.9%</p> <p>mean age: 42</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 1</p> <p>Symptoms/activity: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McLean 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canada</p> <p>community pharmacies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The British Columbia pharmacy asthma study incorporating an asthma care</p> <p>protocol provided by specially trained community pharmacists</p> <p>12 months</p> <p>components: 7</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 119</p> <p>women: 63%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 105</p> <p>women: 62.9%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 4</p> <p>Pt satis: 1</p> <p>QOL: 1</p> <p>Symptoms/activity: 4</p> <p>Self‐care: 1</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Petro 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C‐RCT</p> <p>(provider)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Germany PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A disease management programme with a case manager</p> <p>12 months</p> <p>components: 7</p> <p>dominant component: ORG_HC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 56</p> <p>women: 54.2%</p> <p>mean age: 57.3</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 55</p> <p>women: 44%</p> <p>mean age: 55</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HC use: 2</p> <p>QOL: 3</p> <p>Symptoms/activity: 1</p> <p>Lung function: 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Schatz 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>Kaiser Permanente Medical Care program</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Regular care manager and intensive individualised educational visit</p> <p>12 months</p> <p>components: 11</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 30</p> <p>women: 32.3%</p> <p>mean age: 45</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 15</p> <p>women: 54.8%</p> <p>mean age: 45.4</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 1</p> <p>HC use: 1</p> <p>QOL: 1</p> <p>Symptoms/activity: 2</p> <p>Self‐care: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Smith 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UK</p> <p>outpatient asthma clinics of</p> <p>a hospital and PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The Coping with Asthma Study (a home based, nurse led psychoeducational</p> <p>intervention for adults at risk of adverse asthma outcomes)</p> <p>6 months</p> <p>components: 15</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 42</p> <p>women: 62%</p> <p>mean age: 38.2</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 42</p> <p>women: 84%</p> <p>mean age: 34.7</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>QOL: 6</p> <p>Symptoms/activity: 1</p> <p>Self‐care: 6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wilson 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>Kaiser Permanente clinics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The Better Outcomes of Asthma Treatment (BOAT) study</p> <p>9 months</p> <p>components: 9</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 362</p> <p>women: 56.2%</p> <p>mean age: 46.3</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 189</p> <p>women: 57.4%</p> <p>mean age: 45.1</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 1</p> <p>HC use: 2</p> <p>QOL: 1</p> <p>Symptoms/activity: 5</p> <p>Lung function: 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NRCT</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Herborg 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C‐NRCT</p> <p>(pharmacy)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> <p>community pharmacies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapeutic outcomes monitoring (TOM) programme</p> <p>12 months</p> <p>components: 9</p> <p>dominant component: ORG_PT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 209</p> <p>women: 57.6%</p> <p>mean age: 38.8</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 204</p> <p>women: 54.7%</p> <p>mean age: 42.4</p> <p>moderate‐severe asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Org : 3</p> <p>HC use: 7</p> <p>Pt satis: 1</p> <p>QOL: 2</p> <p>Symptoms/activity: 4</p> <p>Self‐care: 1</p> <p>Lung function: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CBAs</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Feifer 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>PCPs in a region covered by a health insurance company</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Population‐based asthma disease management programme using broad‐based</p> <p>educational interventions</p> <p>12 months</p> <p>components: 7</p> <p>dominant component: mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 35,450</p> <p>women: 56%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 35,450</p> <p>women: 56%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 3</p> <p>HC use: 3</p> <p>QOL: 1</p> <p>Symptoms/activity: 4</p> <p>Self‐care: 3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Landon 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> <p>community health centres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health Disparities Collaboratives disseminating quality improvement techniques</p> <p>54 months</p> <p>components: ≥ 11</p> <p>dominant component: ORG_HC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 1696 (total/2)</p> <p>women: 63.5%</p> <p>mean age: 28.4</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 1696 (total/2)</p> <p>women: 67.6%</p> <p>mean age: 34.4</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 7</p> <p>HC use: 1</p> <p>Symptoms/activity: 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Weng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan</p> <p>outpatient clinics of a</p> <p>hospital and PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A government‐sponsored outpatient‐based disease management programme</p> <p>12 months</p> <p>components: 8</p> <p>dominant component: EDU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 854</p> <p>women: 44.5%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 3188</p> <p>women: 43%</p> <p>mean age: na</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pro satis: 1</p> <p>HC use: 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Windt 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Germany</p> <p>PCPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nationwide asthma disease management programme</p> <p>&gt; 12 months</p> <p>components: ≥ 5</p> <p>dominant component: ORG_HC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N=317</p> <p>women: 48.6%</p> <p>mean age: 36.5</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N=317</p> <p>women: 44.2%</p> <p>mean age: 36.5</p> <p>asthma severity na</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Process: 8</p> <p>HC use: 2</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>RCT: randomised controlled trial, NRCT: non‐randomised controlled trial, CBA: controlled before‐after study, C‐: cluster, PCP: primary care practice, EDU: educational and self‐management support component, ORG_PAT: organisational component targeting patients; ORG_HC organisational component targeting healthcare professionals or the healthcare system, na: not available, HC: healthcare, QOL: quality of life, Org: organisational, Pt satis: patient satisfaction, Pro satis: healthcare professionals' satisfaction </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of characteristics of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/full#CD007988-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007988-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Chronic disease management programme versus usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Asthma‐specific quality of life score (post intervention measurements) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 RCTs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.08, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 NRCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.27, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Subgroup analysis asthma‐specific quality of life score according to the comprehensiveness of the intervention (≥ 8 / &lt; 8 components) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.08, 0.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Comprehensive intervention (≥ 8 components)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1349</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.04, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Less comprehensive intervention (&lt; 8 components)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.12, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Subgroup analysis asthma‐specific quality of life score according to the dominant component of the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.08, 0.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Education and/or self‐management support</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>698</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.11, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.12, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Subgroup analysis asthma‐specific quality of life score according to the presence of limited CDM components in the control group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.08, 0.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Control group without limited CDM components</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.05, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Control group with limited CDM components</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [‐0.03, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Subgroup analysis asthma‐specific quality of life score according to QOL scale <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 AQLQ ‐ overall score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1543</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.12, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 LWAQ ‐ overall score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.16, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Sensitivity analysis asthma‐specific quality of life (change from baseline measurements) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 RCTs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.18, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 NRCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.18, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Self‐efficacy score (post intervention measurements) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>642</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [‐0.08, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Asthma severity score (post intervention measurements) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 RCTs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1330</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.05, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 NRCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.27, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Lung function (FEV1 and PEF) (post intervention measurements) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.09, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 FEV1 (% predicted)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.05, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 PEF (L/min)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.03, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 PEF (% predicted)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐0.01, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 FEV1 (% predicted) (post intervention measurements) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.81 [0.99, 4.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 PEF (L/min) (post intervention measurements) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 RCTs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>33.52 [11.38, 55.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 NRCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>30.52 [7.46, 53.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 PEF (% predicted) (post intervention measurements) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.68 [3.73, 13.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Subgroup analysis lung function according to the comprehensiveness of the intervention (≥ 8 / &lt; 8 components) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.09, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Comprehensive intervention (≥ 8 components)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.07, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Less comprehensive intervention (&lt; 8 components)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>426</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Subgroup analysis lung function according to the dominant component of the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.09, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Education and/or self‐management support</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.04, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Organisation component targeting healthcare system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐0.01, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 Mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>828</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.03, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Subgroup analysis lung function according to the presence of limited CDM components in the control group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.09, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Control group without limited CDM components</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>585</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.02, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Control group with limited CDM components</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>974</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.06, 0.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Chronic disease management programme versus usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007988.pub2/references#CD007988-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007988.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007988-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007988-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007988-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007988-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD007988-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD007988-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="ta#CD007988-note-0005">தமிழ்</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007988\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007988\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007988\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007988\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007988\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007988.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007988.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007988.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007988.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007988.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718734228"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007988.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718734232"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007988.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd78d2b67f47a',t:'MTc0MDcxODczNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 